<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>y55305exv2w1.htm
<DESCRIPTION>EX-2.1: AGREEMENT AND PLAN OF MERGER
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;2.1
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">EXECUTION COPY
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT AND PLAN OF MERGER
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">among

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">SMITHKLINE BEECHAM CORPORATION,

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">FOUNTAIN ACQUISITION CORPORATION

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">and

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">SIRTRIS PHARMACEUTICALS, INC.

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">Dated as of April&nbsp;22, 2008

</DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><DIV style="width: 100%; border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="93%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE I<br>THE OFFER<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 1.1. The Offer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 1.2. Company Consent; Schedule&nbsp;14D-9</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 1.3. Stockholder Lists</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 1.4. Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 1.5. Top-Up Option</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">6</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE II<br>THE MERGER<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 2.1. The Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 2.2. Closing; Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 2.3. Effects of the Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 2.4. Certificate of Incorporation; Bylaws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 2.5. Directors and Officers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 2.6. Special Meeting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 2.7. Merger Without Meeting of Stockholders</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE III<br>
EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 3.1. Conversion of Securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 3.2. Treatment of Equity Awards</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 3.3. Dissenting Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 3.4. Surrender of Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 3.5. Withholding Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">12</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE IV<br>REPRESENTATIONS AND WARRANTIES OF THE COMPANY<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.2. Certificate of Incorporation and Bylaws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">13</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.3. Capitalization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">14</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.4. Authority</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">15</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.5. No Conflict; Required Filings and Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">15</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->i<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE
OF CONTENTS</B><br>(continued)
</DIV>




<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="93%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.6. Compliance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">16</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.7. SEC Filings; Financial Statements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">18</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.8. Absence of Certain Changes or Events</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">20</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.9. Absence of Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">21</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.10. Employee Benefit Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">21</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.11. Labor and Employment Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.12. Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.13. Properties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.14. Tax Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">25</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.15. Schedule&nbsp;14D-9; Offer Documents; Information Statement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">26</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.16. Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">27</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.17. Environmental Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">29</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.18. Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">30</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.19. Affiliate Transactions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">32</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.20. Opinion of Financial Advisor</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">32</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.21. Brokers; Certain Fees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">32</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 4.22. Takeover Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">33</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE V<br>REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.1. Organization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">33</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.2. Authority</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">33</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.3. No Conflict; Required Filings and Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">34</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.4. Absence of Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">34</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.5. Offer Documents; Schedule&nbsp;14D-9; Information Statement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.6. Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.7. Financing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 5.8. Operations of Purchaser</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->ii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE
OF CONTENTS</B><br>(continued)
</DIV>



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="93%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE VI<br>COVENANTS<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.1. Conduct of Business of the Company Pending the Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">36</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.2. Access to Information; Confidentiality</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.3. Acquisition Proposals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.4. Employment and Employee Benefits Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">42</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.5. Directors&#146; and Officers&#146; Indemnification and Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">43</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.6. Further Action; Efforts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">44</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.7. Takeover Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">46</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.8. Information Statement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">46</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.9. Subsequent Filings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">46</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.10. Public Announcements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">47</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.11. Notification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">47</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.12. Approval of Compensation Actions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">47</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.13. Dispositions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">48</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 6.14. No Control of the Company&#146;s Business</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">48</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE VII<br>CONDITIONS OF MERGER<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 7.1. Conditions to Obligation of Each Party to Effect the Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">48</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE VIII<br>TERMINATION, AMENDMENT AND WAIVER<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.1. Termination by Mutual Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">48</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.2. Termination by Either Parent or the Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">49</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.3. Termination by the Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">49</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.4. Termination by Parent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">49</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.5. Effect of Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">50</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.6. Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">51</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.7. Amendment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">52</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 8.8. Waiver</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">52</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->iii<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="93%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="center">ARTICLE IX<br>GENERAL PROVISIONS<BR></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.1. Non-Survival of Representations, Warranties, Covenants and Agreements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">52</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.2. Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">52</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.3. Certain Definitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">53</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.4. Severability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">54</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.5. Entire Agreement; Assignment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">54</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.6. Parties in Interest</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.7. Governing Law</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.8. Headings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.9. Counterparts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.10. Performance Guaranty</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.11. Specific Performance; Jurisdiction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">55</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.12. Interpretation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SECTION 9.13. No Other Representations or Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->iv<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX OF DEFINED TERMS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Acquisition Proposal</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Affiliate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Alternative Acquisition Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARE Warrant</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Audited Balance Sheet</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">beneficial owner</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">beneficially owned</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Business Day</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Bylaws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Capitalization Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Certificate of Incorporation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Certificate of Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Change of Board Recommendation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Code</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Board</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Board Recommendation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Disclosure Schedule</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Employees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Registered Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Requisite Vote</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Stock Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Compensation Actions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Continuing Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Contract</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">control</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Control Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">controlled</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">controlled by</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Copyrights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current Employees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">DGCL</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dissenting Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">DOJ</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">employee benefit plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Environmental Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Environmental Permits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ERISA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ERISA Affiliate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Exchange Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Expiration Date </DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">Exhibit&nbsp;A</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">FDA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Financial Advisor</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Financial Statements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Foreign Antitrust Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">FTC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">GAAP</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Governmental Entity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">GSK</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Hercules Warrant</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HSR Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Indemnified Parties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Indemnified Party</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Independent Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Information Statement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Inventions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">IRS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">knowledge</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Law</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Licensed-In Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Licensed-In Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Liens</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Material Adverse Effect</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Material Contract</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Materials of Environmental Concern</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merger Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center">Exhibit A</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Merger Consideration</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Minimum Tender Condition</DIV></TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center">Exhibit A</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Nasdaq</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Notice Period</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer Conditions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer Documents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Offer Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Option</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Outside Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Owned Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">owns beneficially</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->v<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Disclosure Schedule</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Material Adverse Effect</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Patents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Paying Agent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Permits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Permitted Liens</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Person</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Preferred Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Proceeding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Purchase Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Purchaser</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Purchaser Material Adverse Effect</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Qualifying Proposal</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Qualifying Proposal Notice</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Release</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Restricted Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;14D-9</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;TO</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SEC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SEC Reports</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Securities Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Special Meeting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Subsidiary</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Subsidiary Securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Superior Proposal</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Surviving Corporation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Takeover Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tax</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Tender Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Termination Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Option</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Top-Up Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Trade Secrets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Trademarks</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">under common control with</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Warrants</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->vi<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT AND PLAN OF MERGER
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT AND PLAN OF MERGER, dated as of April&nbsp;22, 2008 (this &#147;<U>Agreement</U>&#148;), among
SmithKline Beecham Corporation, a Pennsylvania corporation (&#147;<U>Parent</U>&#148;), Fountain Acquisition
Corporation, a Delaware corporation and wholly-owned Subsidiary of Parent (&#147;<U>Purchaser</U>&#148;),
and Sirtris Pharmaceuticals, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Parent and the Board of Directors of each of Purchaser and the Company has approved
the acquisition of the Company by Parent on the terms and conditions set forth in this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, on the terms and subject to the conditions set forth herein, Purchaser has agreed to
commence a tender offer (the &#147;<U>Offer</U>&#148;) to purchase all outstanding shares of common stock,
par value $0.001 per share, of the Company (the &#147;<U>Shares</U>&#148;), at a price of $22.50 per Share,
net to the seller in cash (such price, or any higher price as may be paid in the Offer in
accordance with this Agreement, the &#147;<U>Offer Price</U>&#148;), without interest;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, following consummation of the Offer, on the terms and subject to the conditions set
forth herein, Purchaser shall merge with and into the Company (the &#147;<U>Merger</U>&#148;) and each Share
that is issued and outstanding immediately prior to the Effective Time (other than Shares held in
the treasury of the Company or owned by GlaxoSmithKline plc (&#147;<U>GSK</U>&#148;) or any direct or
indirect wholly-owned Subsidiary of GSK or the Company immediately prior to the Effective Time
which will be canceled with no consideration paid in exchange therefor, and other than Dissenting
Shares) will be canceled and converted into the right to receive cash in an amount equal to the
Offer Price, all upon the terms and conditions set forth herein;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of the Company (the &#147;<U>Company Board</U>&#148;) has, on the terms
and subject to the conditions set forth herein, unanimously (i)&nbsp;determined that the transactions
contemplated by this Agreement are fair to, and in the best interests of, the stockholders of the
Company, (ii)&nbsp;approved and declared advisable this Agreement and the transactions contemplated
hereby, including the Offer and the Merger, in accordance with the Delaware General Corporation Law
(the &#147;<U>DGCL</U>&#148;), and (iii)&nbsp;determined to recommend that the Company&#146;s stockholders accept the
Offer and tender their Shares to Purchaser and, to the extent applicable, adopt the &#147;agreement of
merger&#148; (as such term is used in Section&nbsp;251 of the DGCL) set forth in this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of Purchaser has, on the terms and subject to the conditions
set forth herein, unanimously approved and declared advisable this Agreement and the transactions
contemplated hereby, including the Offer and the Merger, and Parent or a wholly-owned Subsidiary of
Parent (in each case, in its capacity as the sole stockholder of Purchaser) has adopted the
&#147;agreement of merger&#148; set forth in this Agreement in each case, in accordance with the DGCL;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, as an inducement to and condition of Parent&#146;s willingness to enter into this
Agreement, the persons listed in <U>Exhibit&nbsp;2(a)</U> have entered into tender and support
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">agreements (the &#147;<U>Tender Agreements</U>&#148;), the form of which is attached as <U>Exhibit
2(b)</U>, immediately prior to the execution and delivery of this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements
herein contained, and intending to be legally bound hereby, Parent, Purchaser and the Company
hereby agree as follows:
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE I
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">THE OFFER

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1.1. <U>The Offer</U>. (a) (i)&nbsp;Provided that this Agreement shall not have been
terminated in accordance with Article&nbsp;VIII and that none of the events set forth in Paragraph (2)
of <U>Exhibit&nbsp;A</U> hereto shall exist or have occurred and be continuing, Purchaser shall, and
Parent shall cause Purchaser to, promptly (but in no event later than the tenth (10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>)
Business Day after the date hereof, provided that the Company shall be prepared to disseminate to
its stockholders its Schedule&nbsp;14d-9 and Schedule&nbsp;14f-1 within such time period) commence (within
the meaning of Rule&nbsp;14d-2 under the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange
Act</U>&#148;)) the Offer to purchase all outstanding Shares at the Offer Price. The obligations of
Purchaser (and of Parent to cause Purchaser) to accept for payment and to pay for any Shares
tendered pursuant to the Offer shall be subject only to the satisfaction or waiver of those
conditions set forth in <U>Exhibit&nbsp;A</U> (the &#147;<U>Offer Conditions</U>&#148;). The initial expiration
date of the Offer shall be the twentieth (20<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>) Business Day following (and including
the day of) the commencement of the Offer. Purchaser expressly reserves the right (but shall not
be obligated) at any time or from time to time in its sole discretion to waive any Offer Condition
or modify or amend the terms of the Offer, except that, without the prior written consent of the
Company, Purchaser shall not (A)&nbsp;decrease the Offer Price or change the form of the consideration
payable in the Offer, (B)&nbsp;decrease the number of Shares sought pursuant to the Offer, (C)&nbsp;amend or
waive the Minimum Tender Condition (as defined in <U>Exhibit&nbsp;A</U>), (D)&nbsp;add to the conditions set
forth on <U>Exhibit&nbsp;A</U>, (E)&nbsp;modify the conditions set forth on <U>Exhibit&nbsp;A</U> in a manner
materially adverse to the holders of Shares, (F)&nbsp;extend the expiration date of the Offer except as
required or permitted by Section&nbsp;1.1(a)(ii) or (G)&nbsp;make any other change in the terms or conditions
of the Offer which is adverse to the holders of Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Subject to the terms and conditions of this Agreement and to the satisfaction or waiver
by Purchaser of the Offer Conditions as of the time of any scheduled expiration of the Offer,
Purchaser shall, and Parent shall cause Purchaser to, accept for payment and pay for Shares validly
tendered and not withdrawn pursuant to the Offer as soon as practicable after such scheduled
expiration and Purchaser shall, and Parent shall cause Purchaser to, immediately accept and
promptly pay for all Shares as they are validly tendered during any subsequent offer period.
Purchaser may, in its sole discretion and without the consent of the Company, (A)&nbsp;extend the Offer
for one or more periods of time of up to twenty (20)&nbsp;Business Days per extension if at any
scheduled expiration of the Offer any of the Offer Conditions are not satisfied (provided, that if
at any such scheduled expiration of the Offer, the Minimum Tender Condition is not satisfied but
all other Offer Conditions are satisfied or waived, then Purchaser shall not be entitled to extend
the Offer for more than thirty (30)&nbsp;Business Days in the aggregate, unless one or more of such
other Offer Conditions ceases to be satisfied), (B)&nbsp;extend
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Offer for any period required by any rule, regulation, interpretation or position of the
Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;) or the staff thereof or The Nasdaq Stock
Market (&#147;<U>Nasdaq</U>&#148;) applicable to the Offer, or (C)&nbsp;after consultation with the Company,
elect (or elect not) to provide a subsequent offering period for the Offer in accordance with Rule
14d-11 under the Exchange Act. The Offer Price may be increased, and the Offer may be extended to
the extent required by Law in connection with such increase in the Offer Price, in each case
without the consent of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Subject to the terms and conditions of this Agreement:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;Purchaser shall extend the Offer on one or more occasions for periods determined by
Purchaser of up to twenty (20)&nbsp;Business Days per extension if, at any scheduled expiration of the
Offer, any of the Offer Conditions has not been satisfied or waived; <U>provided</U>, that if, at
any scheduled expiration of the Offer, any of the circumstances described in the following clauses
(x)&nbsp;or (y)&nbsp;exists, Purchaser shall not be obligated to extend the Offer unless required by
applicable Law or any applicable rule or regulation of Nasdaq (but shall be entitled to extend the
Offer to the extent permitted by clause (ii)&nbsp;above): (x)&nbsp;the Minimum Tender Condition is not
satisfied, but all other Offer Conditions are satisfied or waived; or (y)&nbsp;the Offer Condition set
forth in Paragraph 2(a) of <U>Exhibit&nbsp;A</U> is neither satisfied nor waived (other than by reason
of a judgment, injunction or order that is not final or remains subject to appeal), and Parent and
Purchaser shall have complied with their obligation under Sections&nbsp;6.6(b) and (c); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;if the Company delivers a Qualifying Proposal Notice and, on the date of delivery of such
Qualifying Proposal Notice, the then scheduled expiration of the Offer is a date less than five (5)
Business Days after such date of delivery, then (unless such Qualifying Proposal shall have been
withdrawn prior to such then scheduled expiration of the Offer) Purchaser shall extend the Offer so
that the Expiration Date does not occur until on or after the date that is five (5)&nbsp;Business Days
following the date of delivery of the Qualifying Proposal Notice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>provided</U>, <U>however</U>, that in no circumstance shall Purchaser be required to extend
the Offer (1)&nbsp;beyond the Outside Date or (2)&nbsp;at any time that Parent, Purchaser or the Company is
permitted to terminate and terminates this Agreement pursuant to Article&nbsp;VIII.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;On the date of commencement of the Offer, Parent and Purchaser shall file or cause to be
filed with the SEC a Tender Offer Statement on Schedule&nbsp;TO (collectively with all amendments and
supplements thereto, the &#147;<U>Schedule&nbsp;TO</U>&#148;) with respect to the Offer which shall contain the
offer to purchase and related letter of transmittal and summary advertisement and other ancillary
Offer documents and instruments pursuant to which the Offer will be made (collectively with any
supplements or amendments thereto, the &#147;<U>Offer Documents</U>&#148;). The Company and its counsel
shall be given a reasonable opportunity to review and comment on the Offer Documents prior to their
filing with the SEC. Parent and Purchaser agree (i)&nbsp;to provide the Company with, and to consult
with the Company regarding, any comments that may be received from the SEC or its staff with
respect to the Offer Documents promptly after receipt thereof and prior to responding thereto and
(ii)&nbsp;to provide the Company with any comments or responses thereto. If at any time prior to the
Closing, any information relating to the Offer, the Merger, the Company, Parent, Purchaser or any
of their respective Affiliates, directors or officers, should be
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">discovered by the Company or Parent which should be set forth in an amendment or supplement to
the Offer Documents, so that the Offer Documents shall not contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which they are made, not
misleading, the party which discovers such information shall promptly notify the other party, and
an appropriate amendment or supplement describing such information shall be filed with the SEC and
disseminated to the stockholders of the Company, as and to the extent required by applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent shall provide or cause to be provided to Purchaser on a timely basis the funds
necessary to purchase any Shares that Purchaser becomes obligated to purchase pursuant to the
Offer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1.2. <U>Company Consent; Schedule&nbsp;14D-9</U>. (a)&nbsp;The Company hereby approves of and
consents to the Offer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;On the date the Offer Documents are filed, the Company shall file with the SEC a
Solicitation/Recommendation Statement on Schedule&nbsp;14D-9 (together with all amendments and
supplements thereto, the &#147;<U>Schedule&nbsp;14D-9</U>&#148;) containing, subject to Section&nbsp;6.3(d), the
recommendations of the Company Board described in Section&nbsp;4.4(b). The Company hereby consents to
the inclusion of the recommendations of the Company Board described in Section&nbsp;4.4(b) in the Offer
Documents and to the inclusion of a copy of the Schedule&nbsp;14D-9 with the Offer Documents mailed or
furnished to the Company&#146;s stockholders. Parent and Purchaser shall be given a reasonable
opportunity to review and comment on the Schedule&nbsp;14D-9 prior to its filing with the SEC. The
Company agrees to (i)&nbsp;provide Parent and Purchaser with, and to consult with Parent and Purchaser
regarding, any comments that may be received from the SEC or its staff with respect to the Schedule
14D-9 promptly upon receipt thereof and prior to responding thereto, and (ii)&nbsp;provide Parent and
Purchaser with any comments or responses thereto. If, at any time prior to the Closing, any
information relating to the Offer, the Merger, the Company, Parent, Purchaser or any of their
respective Affiliates, directors or officers should be discovered by the Company or Parent which
should be set forth in an amendment or supplement to the Schedule&nbsp;14D-9 such that the Schedule
14D-9 would not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading, the party which discovers such information
shall promptly notify the other party, and an appropriate amendment or supplement describing such
information shall be filed with the SEC and disseminated to the stockholders of the Company, as and
to the extent required by applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1.3. <U>Stockholder Lists</U>. In connection with the Offer, the Company shall
cause its transfer agent to, promptly (but in any event within two (2)&nbsp;Business Days after the date
hereof), furnish Parent and Purchaser with mailing labels, security position listings and any
available listing or computer file containing the names and addresses of the record holders of the
Shares as of the latest practicable date and shall furnish Parent and Purchaser with such
information and assistance (including periodic updates of such information) as Parent or Purchaser
or their agents may reasonably request in communicating the Offer to the record and beneficial
holders of the Shares. Subject to the requirements of applicable Law, and except for
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such actions as are reasonably necessary to disseminate the Offer Documents and otherwise to
perform its obligations hereunder, each of Parent and Purchaser shall hold all information and
documents provided to it under this Section&nbsp;1.3 in confidence in accordance with the
Confidentiality Agreement, and shall use such information and documents only in connection with the
Offer and the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1.4. <U>Directors</U>. (a)&nbsp;Promptly upon the purchase by Purchaser pursuant to the
Offer of such number of Shares as represents at least a majority of the then-outstanding Shares,
and from time to time thereafter, Purchaser shall be entitled to designate such number of
directors, rounded up to the next whole number, on the Company Board as will give Purchaser
representation on the Company Board equal to the product of (x)&nbsp;the total number of directors on
the Company Board (after giving effect to any increase in the number of directors pursuant to this
Section&nbsp;1.4) and (y)&nbsp;the percentage that such number of Shares so purchased bears to the total
number of Shares outstanding, and the Company shall, upon request by Purchaser, promptly increase
the size of the Company Board or use its reasonable best efforts to secure the resignations of such
number of directors as is necessary to provide Purchaser with such level of representation and
shall cause Purchaser&#146;s designees to be so elected or appointed. The Company shall also use its
reasonable best efforts to cause individuals designated by Purchaser to constitute the same
percentage of each committee of the Company Board (and of each board of directors and each
committee thereof of each wholly-owned Subsidiary of the Company) as the percentage of the entire
Company Board represented by individuals designated by Purchaser. The Company&#146;s obligations to
appoint designees to the Company Board shall be subject to Section 14(f) of the Exchange Act. At
the request of Purchaser, the Company shall take all actions necessary to effect any such election
or appointment of Purchaser&#146;s designees, including mailing to its stockholders the information
required by Section 14(f) of the Exchange Act and Rule&nbsp;14f-l promulgated thereunder which, unless
Purchaser otherwise elects, shall be so mailed together with the Schedule&nbsp;14D-9. Parent and
Purchaser will supply to the Company all information with respect to themselves and their
respective officers, directors and Affiliates required by Section 14(f) of the Exchange Act and
Rule&nbsp;14f-l promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Following the election or appointment of Purchaser&#146;s designees pursuant to Section&nbsp;1.4(a)
and prior to the Effective Time, any amendment or termination of this Agreement requiring action by
the Company Board, any extension of time for the performance of any of the obligations or other
acts of Parent or Purchaser under this Agreement, any waiver of compliance with any of the
agreements or conditions under this Agreement that are for the benefit of the Company, any exercise
of the Company&#146;s rights or remedies under this Agreement and any action to seek to enforce any
obligation of Parent or Purchaser under this Agreement (or any other action by the Company Board
with respect to this Agreement, the Offer or the Merger if such other action adversely affects, or
could reasonably be expected to adversely affect, any of the holders of Shares other than Parent or
Purchaser) may only be authorized by, and will require the authorization of, a majority of the
directors of the Company then in office who are directors of the Company on the date hereof or
their successors as appointed by such continuing directors (the &#147;<U>Continuing Directors</U>&#148;);
<U>provided</U>, <U>however</U>, that if there shall be no Continuing Directors as a result of
such individuals&#146; deaths, disabilities, resignations or refusal to serve, then such actions may be
effected by majority vote of the Independent Directors, or, if no Independent Directors are then in
office, by a majority vote of the Company Board.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In the event that Parent&#146;s designees are elected or appointed to the Company Board
pursuant to Section&nbsp;1.4(a), until the Effective Time, (i)&nbsp;the Company Board shall have at least
such number of directors as may be required by the Nasdaq rules or the federal securities Laws who
are considered independent directors within the meaning of such rules and Laws (&#147;<U>Independent
Directors</U>&#148;) and (ii)&nbsp;each committee of the Company Board that is required (or a majority of
which is required) by the Nasdaq rules or the federal securities Laws to be composed solely of
Independent Directors shall be so composed; <U>provided</U>, <U>however</U>, that in such event,
if the number of Independent Directors shall be reduced below the number of directors as may be
required by such rules or Laws for any reason whatsoever, the remaining Independent Director(s)
shall be entitled to designate persons to fill such vacancies who shall be deemed to be Independent
Directors for purposes of this Agreement or, if no other Independent Director then remains, the
other directors shall designate such number of directors as may be required by the Nasdaq rules and
the federal securities Laws, to fill such vacancies who shall not be stockholders or Affiliates of
Parent or Purchaser, and such Persons shall be deemed to be Independent Directors for purposes of
this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1.5. <U>Top-Up Option</U>. (a)&nbsp;The Company hereby irrevocably grants to Purchaser
an option (the &#147;<U>Top-Up Option</U>&#148;), exercisable in Purchaser&#146;s discretion, but only after the
acceptance by Purchaser of, and payment for, Shares tendered in the Offer, to purchase (for cash or
a note payable) that number (but not less than that number) of Shares (the &#147;<U>Top-Up Shares</U>&#148;)
as is equal to the lowest number of Shares that, when added to the number of Shares owned by GSK,
Parent or Purchaser at the time of such exercise, shall constitute one share more than ninety
percent (90%) of the total Shares then outstanding (assuming the issuance of the Top-Up Shares) at
a price per Share equal to the Offer Price; <U>provided</U>, <U>however</U>, that (i)&nbsp;the Top-Up
Option shall be exercisable only once, at such time as GSK, Parent and Purchaser, directly or
indirectly, own at least eighty-five percent (85%) of the total Shares then outstanding, and only
on or prior to the tenth (10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>) Business Day after the Expiration Date or the expiration
date of any subsequent offering period, (ii)&nbsp;in no event shall the Top-Up Option be exercisable for
a number of Shares in excess of the Company&#146;s then authorized and unissued Shares (including as
authorized and unissued Shares, for purposes of this Section&nbsp;1.5, any Shares held in the treasury
of the Company), and (iii)&nbsp;the Top-Up Option may not be exercised if any provision of applicable
Law or any judgment, injunction, order or decree of any Governmental Entity shall prohibit, or
require any action, consent, approval, authorization or permit of, action by, or filing with or
notification to, any Governmental Entity or the Company&#146;s stockholders in connection with the
exercise of the Top-Up Option or the delivery of the Top-Up Shares in respect of such exercise,
which action, consent, approval, authorization or permit, action, filing or notification has not
theretofore been obtained or made, as applicable. Purchaser shall, concurrently with the exercise
of the Top-Up Option, give written notice to the Company that as promptly as practicable following
such exercise, Purchaser intends to (and Purchaser shall, and Parent shall cause Purchaser to, as
promptly as practicable after such exercise) consummate the Merger in accordance with Section&nbsp;253
of the DGCL as contemplated by Section&nbsp;2.7.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Any certificates evidencing Top-Up Shares may include any legends required by applicable
securities laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent and Purchaser understand that the Shares that Purchaser may acquire upon exercise
of the Top-Up Option will not be registered under the Securities Act of
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">1933, as amended (the &#147;<U>Securities Act</U>&#148;), and will be issued in reliance upon an
exemption thereunder for transactions not involving a public offering. Parent and Purchaser
represent and warrant to the Company that Purchaser is, and will be upon exercise of the Top-Up
Option, an &#147;accredited investor&#148; (as defined in Rule&nbsp;501 of Regulation&nbsp;D promulgated under the
Securities Act). Purchaser agrees that the Top-Up Option and the Top-Up Shares to be acquired upon
exercise thereof are being and will be acquired for the purpose of investment and not with a view
to or for resale in connection with any distribution thereof within the meaning of the Securities
Act.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE II
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">THE MERGER

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.1. <U>The Merger</U>. Upon the terms and subject to the conditions of this
Agreement and in accordance with the DGCL, at the Effective Time, Purchaser shall be merged with
and into the Company. As a result of the Merger, the separate corporate existence of Purchaser
shall cease and the Company shall continue as the surviving corporation of the Merger (the
&#147;<U>Surviving Corporation</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.2. <U>Closing; Effective Time</U>. Subject to the provisions of Article&nbsp;VII, the
closing of the Merger (the &#147;<U>Closing</U>&#148;) shall take place at the offices of Cleary Gottlieb
Steen &#038; Hamilton LLP, One Liberty Plaza, New York, New York, as soon as practicable, but in no
event later than the second (2<SUP style="font-size: 85%; vertical-align: text-top">nd</SUP>) Business Day, after the satisfaction or waiver of the
conditions set forth in Article&nbsp;VII (excluding conditions that, by their terms, cannot be satisfied
until the Closing, but subject to the satisfaction or waiver of such conditions at the Closing), or
at such other place or on such other date as Parent and the Company may mutually agree. The date
on which the Closing actually occurs is hereinafter referred to as the &#147;<U>Closing Date</U>&#148;. At
the Closing, the parties hereto shall cause the Merger to be consummated by filing a certificate of
merger (the &#147;<U>Certificate of Merger</U>&#148;) with the Secretary of State of the State of Delaware,
in such form as required by, and executed in accordance with, the relevant provisions of the DGCL
(the date and time of the filing of the Certificate of Merger with the Secretary of State of the
State of Delaware, or such later time as is specified in the Certificate of Merger and as is agreed
to by the parties hereto, being hereinafter referred to as the &#147;<U>Effective Time</U>&#148;) and shall
make all other filings or recordings required under the DGCL in connection with the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.3. <U>Effects of the Merger</U>. The Merger shall have the effects set forth
herein and in the applicable provisions of the DGCL. Without limiting the generality of the
foregoing and subject thereto, at the Effective Time, all the property, rights, privileges,
immunities, powers and franchises of the Company and Purchaser shall vest in the Surviving
Corporation and all debts, liabilities and duties of the Company and Purchaser shall become the
debts, liabilities and duties of the Surviving Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.4. <U>Certificate of Incorporation; Bylaws</U>. (a)&nbsp;At the Effective Time, the
certificate of incorporation of the Company shall, by virtue of the Merger, be amended and restated
in its entirety to read as the certificate of incorporation of Purchaser in effect immediately
prior to the Effective Time (except that Article&nbsp;I thereof shall read as follows: &#147;The name of the
Corporation is Sirtris Pharmaceuticals, Inc.&#148;) and, as so amended, shall be the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">certificate of incorporation of the Surviving Corporation until thereafter amended in
accordance with its terms and as provided by law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;At the Effective Time, and without any further action on the part of the Company and
Purchaser, the bylaws of the Company shall be amended and restated in their entirety so as to read
as the bylaws of Purchaser as in effect immediately prior to the Effective Time (except that such
bylaws shall be amended to reflect that the name of the Surviving Corporation shall be Sirtris
Pharmaceuticals, Inc.), and, as so amended, shall be the bylaws of the Surviving Corporation until
thereafter amended in accordance with their terms and the certificate of incorporation of the
Surviving Corporation and as provided by law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.5. <U>Directors and Officers</U>. The directors and officers of Purchaser
immediately prior to the Effective Time shall be the directors and officers, respectively, of the
Surviving Corporation, in each case until the earlier of his or her resignation or removal or until
his or her successors are duly elected and qualified.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.6. <U>Special Meeting</U>. Unless the Merger is consummated in accordance with
Section&nbsp;253 of the DGCL as contemplated by Section&nbsp;2.7, and subject to applicable law, the Company,
acting through its Board of Directors, shall, in accordance with applicable law, duly call, give
notice of, convene and hold a special meeting (the &#147;<U>Special Meeting</U>&#148;) of its stockholders
as soon as practicable following the Purchase Time for the purpose of adopting the &#147;agreement of
merger&#148; (as such term is used in Section&nbsp;251 of the DGCL) set forth in this Agreement and include
in the Information Statement the Company Board Recommendation. Parent and Purchaser each agree
that, at the Special Meeting, all of the Shares acquired pursuant to the Offer or otherwise owned
by GSK or any of its respective direct or indirect Subsidiaries will be voted in favor of the
Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.7. <U>Merger Without Meeting of Stockholders</U>. If, following the Offer and any
subsequent offering period or the exercise of the Top-Up Option, Parent and Purchaser (together
with any other direct or indirect wholly-owned Subsidiary of Parent), shall hold in the aggregate
at least ninety percent (90%) of the outstanding shares of each class of capital stock of the
Company, each of Parent, Purchaser and the Company shall (subject to Section&nbsp;7.1) take all
necessary and appropriate action to cause the Merger to become effective, as soon as practicable
after the consummation of the Offer, without a meeting of stockholders of the Company, in
accordance with Section&nbsp;253 of the DGCL.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE III
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">EFFECT OF THE MERGER ON THE CAPITAL STOCK<BR>
OF THE CONSTITUENT CORPORATIONS

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.1. <U>Conversion of Securities</U>. At the Effective Time, by virtue of the
Merger and without any action on the part of Purchaser, the Company or the holders of any of the
following securities, the following shall occur:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;each Share issued and outstanding immediately prior to the Effective Time (other than any
Shares to be canceled pursuant to Section&nbsp;3.1(b) and any Dissenting Shares) shall
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be converted into the right to receive the Offer Price in cash, without interest (the
&#147;<U>Merger Consideration</U>&#148;), payable to the holder thereof upon surrender of such Shares in the
manner provided in Section&nbsp;3.4, less any required withholding Taxes;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;each Share held in the treasury of the Company and each Share owned by GSK or any direct
or indirect wholly-owned Subsidiary of GSK or the Company immediately prior to the Effective Time
shall be canceled and retired without any conversion thereof, and no payment or distribution shall
be made with respect thereto; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;each share of common stock of Purchaser issued and outstanding immediately prior to the
Effective Time shall be converted into one share of common stock of the Surviving Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.2. <U>Treatment of Equity Awards</U>. a) Substantially concurrently with the
approval of this Agreement by the Company Board, the Compensation Committee of the Company Board
has taken all actions so that each option to acquire Shares granted under the Sirtris
Pharmaceuticals, Inc. 2004 Stock Option and Restricted Stock Plan, the Sirtris Pharmaceuticals,
Inc. Amended and Restated 2004 Incentive Plan, or any other Company stock plan (&#147;<U>Company Stock
Plans</U>&#148; and each such option, an &#147;<U>Option</U>&#148;), whether vested or unvested, that is
outstanding and unexercised immediately prior to the purchase of the Shares pursuant to the Offer
(the &#147;<U>Purchase Time</U>&#148;) shall, by virtue of the occurrence of the Purchase Time and without
any action on the part of Purchaser, the Company or the holder thereof, be cancelled and shall
solely represent the right to receive from the Company in exchange, at the Purchase Time or as soon
as practicable thereafter, an amount in cash equal to the product of (i)&nbsp;the number of Shares
subject to such Option and (ii)&nbsp;the excess, if any, of the Offer Price, without interest, over the
exercise price per Share subject to such Option, less any required withholding Taxes, subject to
the withholding arrangements described in the letter, dated April&nbsp;18, 2008, from Nancy Marsh to
Richard Aldrich.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Substantially concurrently with the approval of this Agreement by the Company Board, the
Compensation Committee of the Company Board has taken all actions so that each unvested restricted
stock award (&#147;<U>Restricted Stock</U>&#148;) granted under the Company Stock Plans that is outstanding
immediately prior to the Purchase Time shall, by virtue of the occurrence of the Purchase Time and
without any action on the part of Purchaser, the Company or the holder thereof, be cancelled and
shall solely represent the right to receive from the Company in exchange, at the Purchase Time or
as soon as practicable thereafter, an amount in cash equal to the product of (i)&nbsp;the number of
Shares subject to such award of Restricted Stock and (ii)&nbsp;the Offer Price, without interest, less
any required withholding Taxes subject to the withholding arrangements described in the letter,
dated April&nbsp;18, 2008, from Nancy Marsh to Richard Aldrich.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For the avoidance of doubt, pursuant to such action of the Compensation Committee of the
Company Board described in clause (a), if the exercise price per Share of an Option, whether vested
or unvested as of the Purchase Time, is equal to or greater than the Offer Price, then by virtue of
the occurrence of the Purchase Time and without any action on the part of Purchaser, the Company or
the holder thereof, the Option will be cancelled without payment of any consideration to the
holder.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company Stock Plans shall terminate as of the Purchase Time, and any and all rights
under any provisions in any other plan, program or arrangement, including any Company Plan,
providing for the issuance or grant of any other interest in respect of the capital stock of the
Company (other than the right to receive the payment contemplated by Section&nbsp;3.2(a)) shall be
canceled as of the Purchase Time, except that all administrative and other rights and authorities
granted under the Company Stock Plans to the Company, the Company Board or any committee or
designee thereof shall remain in effect and shall reside with the Company following the Purchase
Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company shall take any actions reasonably necessary to effectuate the provisions of
this Section&nbsp;3.2; it being understood that the intention of the parties is that immediately
following the Purchase Time no holder of any Warrants, Options or Restricted Stock or any
participant in any Company Plan or other employee benefit arrangement of the Company shall have any
right thereunder to acquire any capital stock (including any &#147;phantom&#148; stock or stock appreciation
rights) of the Company, the Surviving Corporation or any of their Subsidiaries pursuant to such
Company Plan or other arrangement. Any notice which the Company shall deliver to the holders of
Options or Restricted Stock or the participants in any other Company Plan setting forth such
holders&#146; rights pursuant to this Agreement shall be reasonably acceptable to Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.3. <U>Dissenting Shares</U>. (a)&nbsp;Notwithstanding anything in this Agreement to
the contrary, Shares that are issued and outstanding immediately prior to the Effective Time and
which are held by holders of Shares that have properly demanded and perfected their rights to be
paid the fair value of such Shares in accordance with Section&nbsp;262 of the DGCL (the &#147;<U>Dissenting
Shares</U>&#148;) shall not be converted into the right to receive the Merger Consideration, and the
holders thereof shall be entitled to only such rights as are granted by Section&nbsp;262 of the DGCL;
<U>provided</U>, <U>however</U>, that if any such holder shall fail to perfect or shall
effectively waive, withdraw or lose such holder&#146;s rights under Section&nbsp;262 of the DGCL, such
holder&#146;s Shares shall not constitute Dissenting Shares and instead shall thereupon be deemed to
have been converted, at the Effective Time, into the right to receive the Merger Consideration, as
set forth in Section&nbsp;3.1 of this Agreement, without any interest thereon.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company shall give Parent (i)&nbsp;reasonably prompt notice of any appraisal demands
received by the Company, withdrawals thereof and any other instruments served pursuant to Section
262 of the DGCL and received by the Company, and (ii)&nbsp;the opportunity to direct all negotiations
and proceedings with respect to the exercise of appraisal rights under Section&nbsp;262 of the DGCL.
The Company shall not, except with the prior written consent of Parent or as otherwise required by
applicable Law, make any payment with respect to any such exercise of appraisal rights or offer to
settle or settle any such rights.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.4. <U>Surrender of Shares</U>. (a)&nbsp;From time to time after the Effective Time,
Parent shall deposit (or cause to be deposited) with a bank or trust company designated by Parent
and reasonably acceptable to the Company (the &#147;<U>Paying Agent</U>&#148;) sufficient funds to timely
make, and shall cause the Paying Agent to timely make, all payments pursuant to Section&nbsp;3.4(b).
Such funds may be invested by the Paying Agent as directed by Parent; provided, that such
investments shall be in short-term obligations of the United States of America with maturities of
no more than thirty (30)&nbsp;days or guaranteed by the United States of America and
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">backed by the full faith and credit of the United States of America or in commercial paper
obligations rated A-1 or P-1 or better by Moody&#146;s Investors Service, Inc. or Standard &#038; Poor&#146;s
Corporation, respectively. Any interest or income produced by such investments will be payable to
the Surviving Corporation or Parent, as Parent directs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Promptly after the Effective Time, the Surviving Corporation shall cause to be mailed to
each record holder, as of the Effective Time, of an outstanding certificate or certificates which
immediately prior to the Effective Time represented Shares (the &#147;<U>Certificates</U>&#148;), a form of
letter of transmittal (which shall be in customary form and shall specify that delivery shall be
effected, and risk of loss and title to the Certificates shall pass, only upon proper delivery of
the Certificates to the Paying Agent) and instructions for use in effecting the surrender of the
Certificates for payment of the Merger Consideration therefor. Upon surrender to the Paying Agent
of a Certificate, together with such letter of transmittal, duly completed and validly executed in
accordance with the instructions thereto, and such other documents as may be required pursuant to
such instructions, the holder of such Certificate shall be entitled to receive in exchange therefor
the Merger Consideration for each Share formerly represented by such Certificate, and such
Certificate shall then be canceled. No interest shall be paid or accrued for the benefit of
holders of the Certificates on the Merger Consideration payable in respect of the Certificates. If
payment of the Merger Consideration is to be made to a Person other than the Person in whose name
the surrendered Certificate is registered, it shall be a condition of payment that the Certificate
so surrendered shall be properly endorsed or shall be otherwise in proper form for transfer and
that the Person requesting such payment shall have paid any transfer and other Taxes required by
reason of the payment of the Merger Consideration to a Person other than the registered holder of
the Certificate surrendered or shall have established to the satisfaction of the Surviving
Corporation that such Tax either has been paid or is not applicable. Until surrendered as
contemplated by this Section&nbsp;3.4(b), each Certificate shall be deemed at any time after the
Effective Time to represent only the right to receive upon such surrender the applicable Merger
Consideration as contemplated by this Article&nbsp;III.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;At any time following the date that is six (6)&nbsp;months after the Effective Time, Parent
shall be entitled to require the Paying Agent to deliver to it any funds (including any interest
received with respect thereto) which have been made available to the Paying Agent and which have
not been disbursed to holders of Certificates and thereafter such holders shall be entitled to look
to the Surviving Corporation (subject to abandoned property, escheat or other similar laws) only as
general creditors thereof with respect to the Merger Consideration payable upon due surrender of
their Certificates. The Surviving Corporation shall pay all charges and expenses, including those
of the Paying Agent, in connection with the exchange of Shares for the Merger Consideration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;After the Effective Time, the stock transfer books of the Company shall be closed and
thereafter there shall be no further registration of transfers of Shares that were outstanding
prior to the Effective Time. After the Effective Time, Certificates presented to the Surviving
Corporation for transfer shall be canceled and exchanged for the consideration provided for, and in
accordance with the procedures set forth in, this Article&nbsp;III.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In the event that any Certificate shall have been lost, stolen or destroyed, upon the
holder&#146;s compliance with the replacement requirements established by the Paying
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Agent, including, if necessary, the posting by the holder of a bond in customary amount as
indemnity against any claim that may be made against it with respect to the Certificate, the Paying
Agent will deliver in exchange for the lost, stolen or destroyed Certificate the applicable Merger
Consideration payable in respect of the Shares represented by such Certificate pursuant to this
Article&nbsp;III.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.5. <U>Withholding Taxes</U>. Notwithstanding anything in this Agreement to the
contrary, Parent, the Surviving Corporation and the Paying Agent shall be entitled to deduct and
withhold from the consideration otherwise payable pursuant to the Offer, the Merger or otherwise
pursuant to this Agreement any amount as may be required to be deducted and withheld with respect
to the making of such payment under applicable Tax Laws. To the extent that amounts are so
properly withheld by the Paying Agent, the Surviving Corporation or Parent, as the case may be, and
are paid to the appropriate Governmental Entity in accordance with applicable Law, such withheld
amounts shall be treated for all purposes of this Agreement as having been paid to the holder of
the Shares or other Person in respect of which such deduction and withholding was made by the
Paying Agent, the Surviving Corporation or Parent, as the case may be.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE IV
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">REPRESENTATIONS AND WARRANTIES OF THE COMPANY

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in (a)&nbsp;the correspondingly numbered Section of the disclosure schedule
delivered by the Company to Parent and Purchaser prior to the execution of this Agreement (the
&#147;<U>Company Disclosure Schedule</U>&#148;) (provided, however, that a matter disclosed with respect to
one representation or warranty shall also be deemed to be disclosed with respect to each other
representation or warranty to which the matter disclosed reasonably relates, but only to the extent
such relationship is reasonably apparent on the face of the disclosure contained in the Company
Disclosure Schedule with respect to such matter) or (b)&nbsp;the Company&#146;s Annual Report on Form 10-K
for the year ended December&nbsp;31, 2007, as filed with the SEC prior to the date hereof, or any
Periodic Report on Form 8-K filed with the SEC after such Form 10-K and prior to the date hereof
(provided, however, that (i)&nbsp;matters disclosed any such report shall be deemed disclosed for
purposes of this Article&nbsp;IV only to the extent apparent on the face of the disclosure contained
therein, and (ii)&nbsp;for this purpose, all disclosures described under &#147;Risk Factors&#148; or which are
cautionary and forward-looking in nature or which otherwise do not relate to historical or existing
facts, events, changes, effects, developments, conditions or occurrences, shall be disregarded),
the Company hereby represents and warrants to Parent and Purchaser as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.1.<U>Organization and Qualification; Subsidiaries</U>. (a)&nbsp;The Company and each of
its Subsidiaries is a duly organized and validly existing corporation or other entity in good
standing (where applicable) under the Laws of its jurisdiction of incorporation or organization,
with all corporate or other entity power and authority to own its properties and conduct its
business as currently conducted and is duly qualified and in good standing as a foreign corporation
or entity authorized to do business in each of the jurisdictions in which the character of the
properties owned or held under lease by it or the nature of the business transacted by it makes
such qualification necessary, except as would not have or reasonably be
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">expected to have, individually or in the aggregate, a Material Adverse Effect. &#147;<U>Material
Adverse Effect</U>&#148; means any change, effect, event or occurrence that has a material adverse
effect on (i)&nbsp;the business, condition (financial or otherwise), operations or results of operations
of the Company and its Subsidiaries, taken as a whole, or (ii)&nbsp;the ability of the Company to timely
perform its obligations under this Agreement or to timely consummate the transactions contemplated
hereby; <U>provided</U>, <U>however</U>, that, in the case of clause (i)&nbsp;only, any changes,
effects, events or occurrences shall not be deemed to constitute a Material Adverse Effect to the
extent resulting from (1)&nbsp;general changes after the date hereof in general economic or market
conditions or in the industries (or therapeutic areas) in which the Company operates; (2)&nbsp;the
announcement or pendency of this Agreement or the transactions contemplated hereby or the
termination, reduction (or potential reduction) or any other adverse development (or potential
adverse development) in the Company&#146;s relationships with any of its customers, suppliers,
distributors or other business partners (provided that this clause (2)&nbsp;shall be deemed not to
include the loss or departure of officers or other employees of the Company); (3)&nbsp;a decrease in the
market price of the Shares in and of itself (and not the underlying causes thereof); (4)&nbsp;acts of
war or terrorism (or the escalation of the foregoing); (5)&nbsp;changes in any Laws or regulations
applicable to the Company or applicable accounting regulations or principles or the interpretation
thereof; (6)&nbsp;the performance of this Agreement and the transactions contemplated hereby including
compliance with covenants set forth herein, or any action taken or omitted to be taken by the
Company at the express written request or with the prior express written consent of Parent or
Purchaser; (7)&nbsp;the fact, in and of itself (and not the underlying causes thereof) that the Company
or its Subsidiaries failed to meet any projections, forecasts, or revenue or earnings predictions;
and (8)&nbsp;natural disasters or other force majeure events, so long as, in the case of clauses (1),
(4), (5)&nbsp;and (8), such changes or events do not have a materially disproportionate effect on the
Company and its Subsidiaries, taken as a whole, compared with other companies operating in the
industries (or therapeutic areas) in which the Company and its Subsidiaries operate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.1(b) of the Company Disclosure Schedule sets forth a list of each Subsidiary of
the Company. The Company, alone or together with one or more of its Subsidiaries, is the record
and beneficial owner of all the equity interests of each Subsidiary of the Company, free and clear
of any Lien, including any limitation or restriction on the right to vote, pledge or sell or
otherwise dispose of such equity interests. Neither the Company nor any of its Subsidiaries owns,
directly or indirectly, beneficially or of record, any interest in any Person other than the
Company&#146;s Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.2. <U>Certificate of Incorporation and Bylaws</U>. The Company has heretofore
made available to Parent true, correct and complete copies of the certificate of incorporation and
bylaws of the Company as currently in effect, including all amendments thereto (respectively, the
&#147;<U>Certificate of Incorporation</U>&#148; and &#147;<U>Bylaws</U>&#148;) and of the certificate of
incorporation and bylaws (or similar governing documents) as currently in effect for each
Subsidiary of the Company. The Certificate of Incorporation and the Bylaws are in full force and
effect and no other organizational documents are applicable to or binding upon the Company. The
Company is not in violation of any provisions of its Certificate of Incorporation or Bylaws in any
material respect.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.3. <U>Capitalization</U>. (a)&nbsp;The authorized capital stock of the Company
consists of (i)&nbsp;100&nbsp;million Shares, and (ii)&nbsp;20&nbsp;million shares of preferred stock, par value $0.001
per share (the &#147;<U>Preferred Stock</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the close of business on April&nbsp;21, 2008 (the &#147;<U>Capitalization Date</U>&#148;): (i)
29,265,360 Shares were issued and outstanding, all of which were validly issued, fully paid and
nonassessable and were issued free of preemptive rights; (ii)&nbsp;an aggregate of 3,722,905 Shares were
reserved for issuance upon or otherwise deliverable in connection with the grant of equity-based
awards or the exercise of outstanding Options issued pursuant to the Company Stock Plans; (iii)&nbsp;no
shares of Preferred Stock were designated, issued or outstanding; (iv)&nbsp;no shares of Common Stock
were held in the treasury of the Company; and (v)&nbsp;85,034 Shares were deliverable upon the exercise
of the Warrant Agreement, dated as of April&nbsp;18, 2006, by and between the Company and Hercules
Technology Growth Capital, Inc. (the &#147;<U>Hercules Warrant</U>&#148;) and 11,905 Shares were deliverable
upon the exercise of the Warrant Agreement, dated as of August&nbsp;1, 2005, by and between the Company
and ARE-770/784/790 Memorial Drive, LLC (the &#147;<U>ARE Warrant</U>&#148; and collectively with the
Hercules Warrant, the &#147;<U>Warrants</U>&#148;). From the close of business on the Capitalization Date
through the date of this Agreement, no options or other rights to acquire Shares or shares of
Preferred Stock have been granted and no Shares or shares of Preferred Stock have been issued or
sold from treasury, except for Shares issued pursuant to the exercise of Options or the Warrants in
accordance with their terms. Section&nbsp;4.3(b) of the Company Disclosure Schedule sets forth, as of
the Capitalization Date, each Option or other equity-based award outstanding under any Company
Plan, the number of Shares issuable thereunder and the expiration date and exercise or conversion
price relating thereto. As of the date hereof, the exercise price of the ARE Warrant is $4.20 and
the exercise price of the Hercules Warrant is $5.88.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as set forth in clauses (a)&nbsp;and (b)&nbsp;of this Section&nbsp;4.3 (including Shares described
therein as reserved for issuance upon the exercise of Options and the Warrants) and for the
Company&#146;s obligations under this Agreement, (i)&nbsp;there are not outstanding or authorized any (A)
shares of capital stock or other voting securities of the Company, (B)&nbsp;securities of the Company
convertible into or exchangeable for shares of capital stock or voting securities of the Company,
or (C)&nbsp;options or other rights to acquire from the Company, or any obligation of the Company to
issue, any capital stock, voting securities or securities convertible into or exchangeable for
capital stock or voting securities of the Company (collectively, &#147;<U>Company Securities</U>&#148;);
(ii)&nbsp;there are no outstanding obligations of the Company to repurchase, redeem or otherwise acquire
any Company Securities; and (iii)&nbsp;there are no other options, calls, warrants or other rights,
agreements, arrangements or commitments of any character relating to any Company Securities to
which the Company is a party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The outstanding shares of capital stock or other equity interests of each of the Company&#146;s
Subsidiaries are duly authorized, validly issued, fully paid and nonassessable, and all such shares
of capital stock or other equity interests are owned beneficially and of record by the Company or
another Subsidiary of the Company, free and clear of all security interests, liens, claims,
pledges, agreements, limitations in voting rights, charges or other encumbrances of any nature
whatsoever (&#147;<U>Liens</U>&#148;) other than Permitted Liens. There are not outstanding or authorized
any (i)&nbsp;securities of any Subsidiary of the Company convertible into or exchangeable for shares of
capital stock or voting securities of any Subsidiary of the Company or (ii)&nbsp;options
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or other rights to acquire from any Subsidiary of the Company, or any obligation of any
Subsidiary of the Company to issue, any capital stock, voting securities or securities convertible
into or exchangeable for capital stock or voting securities of any Subsidiary of the Company
(collectively, &#147;<U>Subsidiary Securities</U>&#148;). There are no outstanding obligations of the
Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Subsidiary
Securities, and there are no other options, calls, warrants or other rights, agreements,
arrangements or commitments of any character relating to any Subsidiary Securities to which the
Company or any of its Subsidiaries is a party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.4. <U>Authority</U>. (a)&nbsp;The Company has all necessary corporate power and
authority to execute and deliver this Agreement, to perform its obligations hereunder and, subject
to the adoption the &#147;agreement of merger&#148; (as such term is used in Section&nbsp;251 of the DGCL)
contained in this Agreement by the Company&#146;s stockholders under the DGCL to the extent required by
applicable Law, to consummate the transactions contemplated hereby. The execution, delivery and
performance of this Agreement by the Company and the consummation by the Company of the
transactions contemplated hereby have been duly and validly authorized by all necessary corporate
action, and no other corporate proceeding on the part of the Company is necessary to authorize this
Agreement or to consummate the transactions so contemplated (other than adoption of the &#147;agreement
of merger&#148; (as such term is used in Section&nbsp;251 of the DGCL) contained in this Agreement by the
holders of at least a majority in combined voting power of the outstanding Shares (the &#147;<U>Company
Requisite Vote</U>&#148;), and the filing with the Secretary of State of the State of Delaware of the
Certificate of Merger as required by the DGCL). This Agreement has been duly and validly executed
and delivered by the Company and, assuming the due authorization, execution and delivery hereof by
Parent and Purchaser, constitutes a legal, valid and binding obligation of the Company enforceable
against the Company in accordance with its terms, subject to the effects of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting
creditors&#146; rights generally, general equitable principles (whether considered in a proceeding in
equity or at law) and any implied covenant of good faith and fair dealing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company Board (at a meeting or meetings duly called and held) has unanimously: (i)
determined that this Agreement and the transactions contemplated hereby, including the Offer and
the Merger, are advisable and fair to and in the best interests of, the Company and its
stockholders; (ii)&nbsp;adopted and approved this Agreement and the transactions contemplated hereby,
including the &#147;agreement of merger&#148; (as such term is used in Section&nbsp;251 of the DGCL) contained in
this Agreement; (iii)&nbsp;directed that the &#147;agreement of merger&#148; (as such term is used in Section&nbsp;251
of the DGCL) contained in this Agreement be submitted to the stockholders of the Company for
adoption (unless the Merger is consummated in accordance with Section&nbsp;253 of the DGCL as
contemplated by Section&nbsp;2.7); and (iv)&nbsp;resolved to recommend acceptance of the Offer and adoption
of the &#147;agreement of merger&#148; (as such term is used in Section&nbsp;251 of the DGCL) contained in this
Agreement by the stockholders of the Company (the &#147;<U>Company Board Recommendation</U>&#148;), which
actions and resolutions have not, as of the date hereof, been subsequently rescinded, modified or
withdrawn in any way.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.5. <U>No Conflict; Required Filings and Consents</U>. (a)&nbsp;The execution,
delivery and performance of this Agreement by the Company, the consummation of the Offer, and,
subject to the adoption of the &#147;agreement of merger&#148; (as such term is used in Section&nbsp;251 of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the DGCL) contained in this Agreement by the Company&#146;s stockholders under the DGCL to the
extent required by applicable Law, the consummation by the Company of the Merger and the other
transactions contemplated hereby, do not and will not, (i)&nbsp;conflict with or violate the Certificate
of Incorporation or Bylaws of the Company, (ii)&nbsp;assuming that all consents, approvals and
authorizations contemplated by clauses (i)&nbsp;through (v)&nbsp;of subsection (b)&nbsp;below have been obtained,
and all filings described in such clauses have been made, conflict with or violate any federal,
state, local or foreign statute, law, ordinance, rule, regulation, order, judgment, decree or legal
requirement (&#147;<U>Law</U>&#148;) or any Nasdaq rule or regulation applicable to the Company or any of
its Subsidiaries or by which any of their respective properties are bound, or (iii) (A)&nbsp;result in
any breach or violation of or constitute a default (or an event which with notice or lapse of time
or both would become a default) under, or (B)&nbsp;result in the loss of a benefit under, or give rise
to any right of termination, cancellation, amendment or acceleration of, or (C)&nbsp;result in the
creation of any Lien on any of the properties or assets of the Company or any of its Subsidiaries
under, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit or other
instrument or obligation (each, a &#147;<U>Contract</U>&#148;) to which the Company or any of its
Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their
respective properties are bound, except, in the case of clauses (ii)&nbsp;and (iii), for any such
conflict, violation, breach, default, loss, right or other occurrence which would not have or
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The execution, delivery and performance of this Agreement by the Company and the
consummation by the Company of the transactions contemplated hereby, do not and will not require
any consent, approval, authorization or permit of, action by, filing with or notification to, any
federal, state, local or foreign governmental or regulatory (including stock exchange) authority,
agency, court, commission, or any other governmental body (each, a &#147;<U>Governmental Entity</U>&#148;),
except for (i)&nbsp;applicable requirements of the Exchange Act and the rules and regulations
promulgated thereunder (including the filing of the Information Statement), and state securities,
takeover and &#147;blue sky&#148; laws, (ii)&nbsp;the applicable requirements of the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the &#147;<U>HSR Act</U>&#148;), (iii)&nbsp;the applicable requirements of
Nasdaq, (iv)&nbsp;the filing with the Secretary of State of the State of Delaware of the Certificate of
Merger as required by the DGCL, (v)&nbsp;the applicable requirements of antitrust or other competition
laws of jurisdictions other than the United States or investment laws relating to foreign ownership
(&#147;<U>Foreign Antitrust Laws</U>&#148;), and (vi)&nbsp;any such consent, approval, authorization, permit,
action, filing or notification the failure of which to make or obtain would not have or reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.6. <U>Compliance</U>. (a)&nbsp;The Company and each of its Subsidiaries is and at all
times has been in compliance in all material respects with all Laws applicable to the Company or
any of its Subsidiaries or by which any of their respective properties are bound, including Laws
enforced by the U.S. Food and Drug Administration (&#147;<U>FDA</U>&#148;) and comparable foreign
Governmental Entities. The Company and its Subsidiaries have all registrations, applications,
licenses, requests for exemptions, permits and other regulatory authorizations (&#147;<U>Permits</U>&#148;)
from Governmental Entities required to conduct their respective businesses. The Company and its
Subsidiaries are in compliance in all material respects with all such Permits, and any third party
that is a manufacturer or contractor for the Company or any of its Subsidiaries has and is in
compliance in all material respects with all Permits from the FDA and
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">comparable foreign Governmental Entities insofar as the same are required for or pertain to
the manufacture or handling of product components or products for the Company or any of its
Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the Company nor any Subsidiary of the Company has either voluntarily or
involuntarily initiated, conducted, or issued any recall, market withdrawal, safety alert, warning,
&#147;dear doctor&#148; letter, investigator notice, or other notice relating to an alleged lack of safety or
efficacy of any product or product candidate of the Company or any Subsidiary of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;All reports, documents, claims and notices required to be filed, maintained, or furnished
to the FDA or other drug regulatory agency by the Company or any Subsidiary of the Company have
been so filed, maintained or furnished and were complete and correct in all material respects on
the date filed (or were corrected in or supplemented by a subsequent filing).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company and each Subsidiary of the Company is in material compliance with all
applicable Laws, regulatory or warning letters, notices of adverse findings, and any other letters
or notices issued or administered by the FDA or other drug regulatory agency. There are no pending
or, to the knowledge of the Company, threatened regulatory actions (other than non-material routine
or periodic inspections or reviews) against any of the Company, the Company&#146;s Subsidiaries or, with
respect to the products of the Company, any Person that manufactures or develops the products of
the Company or any Subsidiary of the Company or product candidates pursuant to a development,
commercialization, manufacturing, supply or other collaboration arrangement with the Company or any
of the Company Subsidiaries by the FDA or any authorized Governmental Entity, which regulates the
sale of drugs in any jurisdiction. The Company has not received any written notices from the FDA
or other drug regulatory agency alleging or asserting noncompliance with any applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Each product (or product candidate in clinical trials as of the date hereof) of the
Company or any Subsidiary of the Company is and has been developed, tested, manufactured and stored
by or on behalf of the Company or any of its Subsidiaries in compliance with the U.S. Federal Food,
Drug, and Cosmetic Act, as amended, and applicable regulations promulgated thereunder, and all
applicable similar Laws in foreign jurisdictions, including those requirements relating to &#147;good
manufacturing practice,&#148; &#147;good laboratory practice&#148; and &#147;good clinical practice,&#148; as defined by the
FDA, and all applicable Law. There have not been any recalls, whether voluntary or otherwise, of
products manufactured distributed or sold by or on behalf of the Company or any Subsidiary of the
Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;None of the Company, the Company&#146;s Subsidiaries or, to the knowledge of the Company, any
of their respective employees, agents or subcontractors, has been convicted of any crime or engaged
in any conduct which could result in debarment or disqualification by the FDA or any drug
regulatory agency, and there are no proceedings pending or, to the knowledge of the Company,
threatened that reasonably might be expected to result in criminal liability or debarment or
disqualification by the FDA or any drug regulatory agency.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;There are no &#147;serious adverse events&#148; (as such term is defined in 21 C.F.R. 312.32)
associated with clinical trials of the products or product candidates of the Company or any
Subsidiary of the Company, whether conducted by the Company, any Subsidiary of the Company or any
other Person, that have not been reported to the FDA and other applicable drug regulatory agencies
in accordance with applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;All studies, tests, and preclinical and clinical trials being conducted by the Company or
any Subsidiary of the Company are being conducted in material compliance with experimental
protocols, procedures and controls pursuant to generally accepted professional scientific
standards, &#147;good laboratory practices,&#148; as applicable, and &#147;good clinical practices&#148; as defined by
the FDA, and all applicable Law. Neither the Company nor any Subsidiary of the Company has
received any written notices from the FDA or any other Governmental Entity requiring the
termination, suspension, or material modification of any clinical trials conducted by the Company
or any Subsidiary of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;To the knowledge of the Company, the Company has, prior to the date hereof, provided or
made available to Parent in the electronic data room all material documents and data relating to
the results of all assays, preclinical and clinical trials, and any other tests, experiments,
analysis or investigations conducted by or on behalf of the Company with respect to each product or
product candidate or existing compound of the Company, to the extent such documents and data exist
in tangible form and are in the possession of the Company or its Subsidiaries prior to the
execution of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.7. <U>SEC Filings; Financial Statements</U>. (a)&nbsp;The Company has filed or
otherwise transmitted all forms, reports, statements, certifications and other documents (including
all exhibits, amendments and supplements thereto) required to be filed or transmitted by it with or
to the SEC since March&nbsp;1, 2007 (such documents filed or otherwise transmitted since March&nbsp;1, 2007
and prior to the date hereof, the &#147;<U>SEC Reports</U>&#148;). As of their respective dates, each of
the SEC Reports complied as to form in all material respects with the applicable requirements of
the Securities Act and the rules and regulations promulgated thereunder and the Exchange Act and
the rules and regulations promulgated thereunder, each as in effect on the date so filed. Except
to the extent amended or superseded by a subsequent filing with the SEC made prior to the date
hereof, as of their respective dates (and if so amended or superseded, then on the date of such
subsequent filing), none of the SEC Reports contained any untrue statement of a material fact or
omitted to state a material fact required to be stated or incorporated by reference therein or
necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The audited and unaudited consolidated financial statements (including the related notes
thereto) of the Company included (or incorporated by reference) in the SEC Reports (the
&#147;<U>Financial Statements</U>&#148;), as amended or supplemented prior to the date of this Agreement,
have been prepared in accordance with GAAP in all material respects applied on a consistent basis
throughout the periods involved (except as may be indicated in the notes thereto) and fairly
present in all material respects in conformity with GAAP the consolidated financial position of the
Company and its consolidated Subsidiaries at the respective dates thereof and the consolidated
statements of operations, cash flows and changes in stockholders&#146; equity for the periods indicated
therein (subject, in the case of unaudited financial statements, to normal and
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">recurring year-end audit adjustments which are not, individually or in the aggregate, material
in amount or significance, in each case as permitted by GAAP and the applicable rules and
regulations promulgated by the SEC).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The records, systems, controls, data and information of the Company and its Subsidiaries
are recorded, stored, maintained and operated under means (including any electronic, mechanical or
photographic process, whether computerized or not) that are under the exclusive ownership and
direct control of the Company or its accountants (including all means of access thereto and
therefrom), except for any nonexclusive ownership and nondirect control that has not had and would
not reasonably be expected to have, individually or in the aggregate, a material adverse effect on
the system of internal accounting controls described below in this Section&nbsp;4.7(c). The Company has
implemented and maintains a system of internal control over financial reporting (as required by
Rule&nbsp;13a-15(a) under the Exchange Act) that is designed to provide reasonable assurances regarding
the reliability of financial reporting and the preparation of its consolidated financial statements
for external purposes in accordance with GAAP, and to the knowledge of the Company, such system of
internal control over financial reporting is effective. For purposes of this Section&nbsp;4.7(c),
&#147;knowledge of the Company&#148; means the actual knowledge after due inquiry of the Chief Executive
Officer; the Chief Operating Officer; the Vice President, Finance; and the Assistant Comptroller,
and shall not have the meaning ascribed thereto in Section&nbsp;9.3(f). The Company has implemented and
maintains disclosure controls and procedures (as required by Rule&nbsp;13a-15(a) of the Exchange Act)
that are designed to ensure that information required to be disclosed by the Company in the reports
it files or submits under the Exchange Act is recorded, processed, summarized and reported within
the time frames specified by the SEC&#146;s rules and forms (and such disclosure controls and procedures
are effective), and (ii)&nbsp;has disclosed, based on its most recent evaluation of its system of
internal control over financial reporting prior to the date of this Agreement, to the Company&#146;s
outside auditors and the audit committee of the Company&#146;s Board of Directors (A)&nbsp;any significant
deficiencies and material weaknesses, to the knowledge of the Company, in the design or operation
of its internal control over financial reporting (as defined in Rule&nbsp;13a-15(f) of the Exchange Act)
that would reasonably be expected to adversely affect the Company&#146;s ability to record, process,
summarize and report financial information and (B)&nbsp;any fraud, to the knowledge of the Company, that
involves management or other employees who have a significant role in the Company&#146;s internal
controls over financial reporting. Prior to the date hereof, a true, correct and complete summary
of any such disclosures made by management to the Company&#146;s auditors and the audit committee of the
Company&#146;s Board of Directors has been provided to Parent and is set forth as Section&nbsp;4.7(c) of the
Company Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Since March&nbsp;1, 2007, (i)&nbsp;neither the Company nor any of its Subsidiaries nor, to the
knowledge of the Company, any director, officer, employee, auditor, accountant or representative of
the Company or any of its Subsidiaries has received or otherwise had or obtained knowledge of any
material complaint, allegation, assertion or claim, whether written or oral, regarding the
accounting or auditing practices, procedures, methodologies or methods of the Company or any of its
Subsidiaries or their respective internal accounting controls, including any material complaint,
allegation, assertion or claim that the Company or any of its Subsidiaries has engaged in
questionable accounting or auditing practices, and (ii)&nbsp;no attorney representing the Company or any
of its Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has
reported evidence of a material violation of securities Laws, breach of fiduciary
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">duty or similar violation by the Company or any of its Subsidiaries or any of their respective
officers, directors, employees or agents to the Company Board or any committee thereof or to any
director or officer of the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;To the knowledge of the Company, as of the date hereof, no employee of the Company nor any
of its Subsidiaries has provided or is providing information to any law enforcement agency
regarding the commission or possible commission of any crime or the violation or possible violation
of any applicable Law of the type described in Section&nbsp;806 of the Sarbanes-Oxley Act by the Company
or any of its Subsidiaries. Neither the Company or any of its Subsidiaries nor, to the knowledge
of the Company, any director, officer, employee, contractor, subcontractor or agent of the Company
or any of its Subsidiaries has discharged, demoted, suspended, threatened, harassed or in any other
manner discriminated against an employee of the Company or any of its Subsidiaries in the terms and
conditions of employment because of any lawful act of such employee described in Section&nbsp;806 of the
Sarbanes-Oxley Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Neither the Company nor any of its Subsidiaries has any liabilities of any nature, whether
accrued, absolute, fixed, contingent or otherwise, known or unknown, whether due or to become due
and whether or not required to be recorded on a balance sheet under GAAP, that would, individually
or in the aggregate, reasonably be expected to be material to the Company and its Subsidiaries,
taken as a whole, other than liabilities (i)&nbsp;as and to the extent reflected or reserved against on
the Audited Balance Sheet or in the notes thereto, (ii)&nbsp;incurred in the ordinary course of business
consistent with past practice since the December&nbsp;31, 2007, (iii)&nbsp;arising from contractual
obligations to be performed after the date hereof under Contracts set forth in Section&nbsp;4.18 of the
Company Disclosure Schedule or other Contracts not required to be listed therein (but excluding any
obligations or liabilities that arise in connection with any Contract as a result of any breach or
default at or prior to the Purchase Time under such Contract), (iv)&nbsp;resulting from the Company&#146;s
compliance with clauses (a)&nbsp;through (n)&nbsp;of Section&nbsp;6.1, or (v)&nbsp;that are investment banking,
accounting and legal fees incurred by the Company in connection with the negotiation, execution and
delivery of this Agreement. The &#147;<U>Audited Balance Sheet</U>&#148; means the consolidated balance
sheet of the Company dated as of December&nbsp;31, 2007 included in the Company&#146;s Annual Report on Form
10-K for the twelve (12)-month period ended December&nbsp;31, 2007 filed with the SEC prior to the date
hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.8. <U>Absence of Certain Changes or Events</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Since December&nbsp;31, 2007 through the date of this Agreement, the Company and its
Subsidiaries have conducted their business only in the ordinary course consistent with past
practice, and neither the Company nor any of its Subsidiaries has taken any action since December
31, 2007 that, if taken after the date of this Agreement without the prior written consent of
Parent, would constitute a breach of Section&nbsp;6.1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Since December&nbsp;31, 2007, there has not been (and there is not) any change, condition,
event or development that has had, or would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Compensation Committee of the Company Board is (and at all times since March&nbsp;1, 2007
was, and at all times from the date of this Agreement to the first date on
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">which the Purchaser&#146;s designees constitute a majority of the Company Board pursuant to Section
1.4 will be) composed solely of Independent Directors. Since October&nbsp;1, 2007, neither the Company
nor any of its Subsidiaries has done any of the following except as has been approved, as an
employment compensation, severance or other employee benefit arrangement, by the Compensation
Committee of the Company Board (and, to the extent any of the following was so approved after the
date of the first discussion of a possible tender offer or merger by the Company with Parent or one
of its Affiliates, the Compensation Committee of the Company Board was, at the time of each such
approval, aware of the status of such potential tender offer or merger) in accordance with the
requirements of Rule&nbsp;14d-10(d)(2) under the Exchange Act and the instructions thereto: (i)&nbsp;any
granting by the Company or any of its Subsidiaries to any present or former director, officer or
employee of any increase in compensation or benefits in any form or of the right to receive any
severance or termination compensation or benefit, or any approval, amendment or modification of any
such grant; or (ii)&nbsp;any entry by the Company by the Company or any of its Subsidiaries into any
employment, consulting, indemnification, termination, change of control, non-competition or
severance agreement or arrangement with any present or former director, officer or employee, or any
approval, amendment or modification of any such agreement or arrangement; or (iii)&nbsp;any approval,
amendment to or adoption of any Company Plan (the matters described in foregoing clauses (i), (ii)
and (iii), collectively, &#147;<U>Compensation Actions</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.9. <U>Absence of Litigation</U>. (a)&nbsp;There is no claim, action, suit, proceeding,
arbitration, mediation or investigation by or before any Governmental Entity (each, a
&#147;<U>Proceeding</U>&#148;) pending (or, to the knowledge of the Company, threatened in writing) to which
the Company or any of its Subsidiaries is a party or against the Company or any of its Subsidiaries
or any of its or their properties or assets, other than any such Proceeding that (i)&nbsp;does not
involve an amount in controversy in excess of $100,000, (ii)&nbsp;does not seek injunctive or other
non-monetary relief, and (iii)&nbsp;would not have or reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect. As of the date hereof, neither the Company nor any of
its Subsidiaries nor any of their respective properties or assets is subject to any outstanding
order, writ, injunction or decree, except as would not have or reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.9(b) of the Company Disclosure Schedule sets forth an accurate and complete list
of each Proceeding resolved or settled since March&nbsp;25, 2004 and prior to the date of this Agreement
and requiring payment by the Company or any of its Subsidiaries in excess of $100,000 or involving
the imposition on the Company or any of its Subsidiaries of injunctive or other non-monetary
relief.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;To the knowledge of the Company, no officer or director of the Company or any of its
Subsidiaries is a defendant in any Proceeding in connection with his or her status as an officer or
director of the Company or any of its Subsidiaries, and to the knowledge of the Company, no such
Proceeding is threatened.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.10. <U>Employment Agreements and Employee Benefit Plans</U>. (a)&nbsp;Section&nbsp;4.10(a)
of the Company Disclosure Schedule contains a true and complete list of each material &#147;employee
benefit plan&#148; (within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act of
1974, as amended (&#147;<U>ERISA</U>&#148;)) and each other employment,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">bonus, vacation, stock option, stock purchase, restricted stock or other equity-based,
incentive, deferred compensation, profit sharing, savings, retirement, retiree medical or life
insurance, supplemental retirement, severance, fringe benefit, retention, change of control or
other benefit plans, programs, agreements, contracts, policies or arrangements contributed to,
sponsored or maintained by the Company as of the date hereof for the benefit of any current, former
or retired employee, officer, consultant, independent contractor or director of the Company
(collectively, the &#147;<U>Company Employees</U>&#148;) or to which the Company is a party or with respect
to which the Company has or would reasonably be expected to have any liability (such plans,
programs, policies, agreements and arrangements, including the Company Stock Plans, collectively,
&#147;<U>Company Plans</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;With respect to each Company Plan, the Company has made available to Parent a current,
accurate and complete copy thereof (or, if a plan is not written, a written description thereof)
and, to the extent applicable, (i)&nbsp;any related trust agreement or other funding instrument, (ii)
the most recent determination letter received from the Internal Revenue Service (the &#147;<U>IRS</U>&#148;)
for each Company Plan that is intended to be qualified under Section 401(a) of the Internal Revenue
Code of 1986, as amended (the &#147;<U>Code</U>&#148;), (iii)&nbsp;the most recent summary plan description and
any summaries of any material modification of such Company Plan, (iv)&nbsp;all prospectuses prepared in
connection with any such Plan, (v)&nbsp;any participant communications made since October&nbsp;1, 2007, that
could reasonably be expected to give rise to a material liability and (vi)&nbsp;for the most recent year
(A)&nbsp;the Form&nbsp;5500 and attached schedules, (B)&nbsp;audited financial statements, and (C)&nbsp;actuarial
valuation reports, if any.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as would not have or reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, (i)&nbsp;each Company Plan has been established and administered
in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code,
and other applicable laws, rules and regulations; (ii)&nbsp;no &#147;prohibited transaction,&#148; within the
meaning of Section&nbsp;4975 of the Code or Sections&nbsp;406 or 407 of ERISA, and not otherwise exempt under
Section&nbsp;408 of ERISA, has occurred with respect to any Company Plan; and (iii)&nbsp;all contributions,
premiums and other payments required to be made with respect to each Company Plan have been made on
or before their due dates under applicable Law and the terms of such Company Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Neither the Company or any of its Subsidiaries nor any other Person that, together with
the Company or any of its Subsidiaries, is or was treated as a single employer under Section
414(b), (c), (m)&nbsp;or (o)&nbsp;of the Code (each, together with the Company, an &#147;<U>ERISA
Affiliate</U>&#148;), is now contributing to or has any material liability to, or has at any time within
the past six (6)&nbsp;years (and in the case of any such other Person, only during the period within the
past six (6)&nbsp;years that such other Person was an ERISA Affiliate) contributed to or had any
material liability to (i)&nbsp;a pension plan (within the meaning of Section&nbsp;3(2) of ERISA) subject to
Section&nbsp;412 of the Code or Title IV of ERISA; (ii)&nbsp;a multiemployer plan (within the meaning of
Section&nbsp;3(37) or 4001(a)(3) of ERISA); or (iii)&nbsp;a single employer pension plan (within the meaning
of Section&nbsp;4001(a)(15) of ERISA) for which an ERISA Affiliate would reasonably be expected to incur
liability under Section&nbsp;4063 or 4064 of ERISA.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;No Proceedings (other than routine claims for benefits in the ordinary course) are pending
or, to the knowledge of the Company, threatened with respect to any Company Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Except as set forth in Section&nbsp;4.10 of the Company Disclosure Schedule, no Company Plan
provides post-termination welfare benefits, and neither the Company nor any of its Subsidiaries has
any obligation to provide any post-termination welfare benefits, in each case, other than health
care continuation as required by Section&nbsp;4980B of the Code or similar Law of any state or foreign
jurisdiction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Each Company Plan which is intended to be qualified under Section 401(a) of the Code is so
qualified and has received a favorable determination letter from the IRS and, to the knowledge of
the Company, no circumstances exist which would reasonably be expected to materially and adversely
affect such favorable determination.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Except as set forth in Section&nbsp;4.10(h) of the Company Disclosure Schedule, neither the
execution by the Company of this Agreement nor the consummation of the transactions contemplated
hereby will or may (either alone or upon occurrence of any subsequent termination of employment of
any current Company Employee of the Company) (i)&nbsp;result in any payment, acceleration, forgiveness
of indebtedness, vesting, distribution, increase in benefits or obligation to fund benefits, or any
similar consequence with respect to any Company Plan or (ii)&nbsp;result in the failure of any amount to
be deductible by reason of Section&nbsp;280G of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;All Options and other equity-based awards under Company Plans (i)&nbsp;have been granted in
compliance, all material respects, with the terms of the applicable Company Plans, with applicable
Laws, and with the applicable provisions of the Company&#146;s certificate of incorporation and bylaws
as in effect at the time of the applicable grant, and (ii)&nbsp;are accurately disclosed as required by
applicable Law in (x)&nbsp;the SEC Reports and the Financial Statements and (y)&nbsp;the Tax returns of the
Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.11. <U>Labor and Employment Matters</U>. (a)&nbsp;Neither the Company nor any of its
Subsidiaries is a party to or is bound by any collective bargaining agreement or any labor union
contract, nor, to the knowledge of the Company, are there any employees of the Company or any of
its Subsidiaries represented by a works&#146; council or a labor organization, nor are there any
activities or proceedings of any labor union to organize any employees of the Company or any of its
Subsidiaries or compel the Company or any of its Subsidiaries to bargain with any labor union or
labor organization. There is no pending or, to the knowledge of the Company, threatened labor
strike, walkout, work stoppage, or lockout with respect to employees of the Company or any of its
Subsidiaries. No grievance or arbitration demand or proceeding, or unfair labor practice charge or
proceeding, whether or not filed pursuant to a collective bargaining agreement, has been filed, is
pending or, to the knowledge of the Company, has been threatened against the Company or any of its
Subsidiaries that would have or would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the knowledge of the Company, the Company and its Subsidiaries are in compliance in all
material respects with all applicable Laws relating to labor and employment, including Laws
relating to discrimination, disability, labor relations, hours of work, payment of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">wages and overtime wages, pay equity, immigration, workers compensation, working conditions,
employee scheduling, occupational safety and health, family and medical leave, notification, and
employee terminations. Except as would not result in any material liability to the Company, there
are no complaints, lawsuits, arbitrations, administrative proceedings, or other Proceedings pending
or, to the knowledge of the Company, threatened against the Company brought by or on behalf of any
applicant for employment, any current or former employee, any person alleging to be a current or
former employee, any class of the foregoing, or any Governmental Entity, relating to any such Law
or regulation, or alleging breach of any express or implied contract of employment, wrongful
termination of employment, or alleging any other discriminatory, wrongful or tortious conduct in
connection with the employment relationship.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as would not result, individually or in the aggregate, in any material liability to
the Company, with respect to any person who provides personal services to the Company, (i)&nbsp;the
Company has classified each such service provider as either an &#147;employee&#148; or an &#147;independent
contractor&#148; and has had a reasonable basis for each such determination; (ii)&nbsp;such classifications
have, to the knowledge of the Company, been consistent among service providers who provide similar
services and are otherwise similarly situated; (iii)&nbsp;no person who is classified, or was
classified, as an independent contractor has been classified as an employee of the Company at any
other time; (iv)&nbsp;all Company tax returns have been filed on a basis consistent with such
classifications; (v)&nbsp;such classifications have, to the knowledge of the Company, complied in all
material respects with applicable laws; (vi)&nbsp;all employees have, to the knowledge of the Company,
been properly treated in all material respects under all Company Plans; and (vii)&nbsp;there are no
complaints, actions, claims or proceedings pending, or to the knowledge of the Company, threatened
to be brought, by any such person or governmental body to reclassify any employee or independent
contractor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.12. <U>Insurance</U>. Section&nbsp;4.12 of the Company Disclosure Schedule sets forth,
as of the date hereof, a true, correct and complete list of all material insurance policies issued
in favor of the Company or any of its Subsidiaries, or pursuant to which the Company or any of its
Subsidiaries is a named insured or otherwise a beneficiary, as well as any historic
incurrence-based policies still in force. With respect to each such insurance policy, (i)&nbsp;the
policy is in full force and effect and all premiums due thereon have been paid, (ii)&nbsp;neither the
Company nor any of its Subsidiaries is in breach or default, and to the knowledge of the Company,
neither the Company nor any of its Subsidiaries has taken any action or failed to take any action
which with notice or the lapse of time, would constitute such a breach or default, or permit
termination or modification of, any such policy, and (iii)&nbsp;to the knowledge of the Company, no
insurer on any such policy has been declared insolvent or placed in receivership, conservatorship
or liquidation, and no notice of cancellation or termination has been received with respect to any
such policy.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.13. <U>Properties</U>. Except as would not have or reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect, the Company: (a)&nbsp;has good title
to all tangible personal property reflected in the latest balance sheet included in the SEC Reports
as being owned by the Company or one of its Subsidiaries or acquired after the date thereof (except
properties sold or otherwise disposed of since the date thereof in the ordinary course of business
consistent with past practice), free and clear of all Liens, except (i)&nbsp;statutory Liens for current
Taxes or other governmental charges not yet due and payable or the amount or
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">validity of which is being contested in good faith by appropriate proceedings, (ii)&nbsp;Liens
arising under worker&#146;s compensation, unemployment insurance, social security, retirement and
similar legislation, (iii)&nbsp;other statutory liens securing payments not yet due, (iv)&nbsp;purchase money
Liens and Liens securing rental payments under capital lease arrangements, (v)&nbsp;such imperfections
or irregularities of title, claims, liens, charges, security interests, easements, covenants and
other restrictions or encumbrances as do not materially affect the use of the properties or assets
subject thereto or affected thereby or otherwise materially impair business operations at such
properties, (vi)&nbsp;mortgages, or deeds of trust, security interests or other encumbrances on title
related to indebtedness reflected on the financial statements included in the Financial Statements
and (vii)&nbsp;other Liens being contested in good faith in the ordinary course of business or which
would not have or reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect (collectively, the &#147;<U>Permitted Liens</U>&#148;); and (b)&nbsp;is the lessee of all
leasehold estates reflected in the latest Financial Statements or acquired after the date thereof
(except for leases that have expired by their terms since the date thereof or been assigned,
terminated or otherwise disposed of in the ordinary course of business) and is in possession of the
properties purported to be leased thereunder, and each such lease is valid without material default
thereunder by the lessee or, to the Company&#146;s knowledge, the lessor. The Company does not own any
real property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.14. <U>Tax Matters</U>. (a)&nbsp;Except as would not have or reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect: (i)&nbsp;the Company has timely filed
or caused to be filed all returns and reports relating to Taxes required to be filed by applicable
Law with respect to the Company or any of its Subsidiaries or any of its or their income,
properties or operations; (ii)&nbsp;the Company has paid all Taxes shown thereon as owing; and (iii)&nbsp;all
such returns are true, correct and complete.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company has made adequate provisions in accordance with GAAP, appropriately and
consistently applied, in the Financial Statements for the payment of all material Taxes for which
the Company or any of its Subsidiaries may be liable for the periods covered thereby that were not
yet due and payable as of the dates thereof, regardless of whether the liability for such Taxes is
disputed.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;To the knowledge of the Company, neither the Company nor any of its Subsidiaries has
received any written claim or assessment against the Company or any of its Subsidiaries for any
alleged material deficiency in Taxes, and, to the knowledge of the Company, there is no outstanding
audit or investigation with respect to any material liability of the Company or any of its
Subsidiaries for Taxes. There are no agreements in effect to extend the period of limitations for
the assessment or collection of any material Tax for which the Company or any of its Subsidiaries
may be liable, and no closing agreement pursuant to Section&nbsp;7121 of the Code or any predecessor
provision thereof, or any similar provision of state or local Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Except as would not have or reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, the Company and its Subsidiaries have withheld from payments
to their employees, independent contractors, creditors, shareholders and any other applicable
Person (and timely paid to the appropriate taxing authority) proper and accurate amounts in
compliance with the Tax withholding provisions of applicable Laws (including income, social
security, and employment Tax withholding for all types of compensation and
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">withholding of Tax on dividends, interest, and royalties and similar income earned by
nonresident aliens and foreign corporations).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Except as would not have or reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, there is no obligation of the Company or any of its
Subsidiaries to contribute to the payment of any Tax or any portion of a Tax (or any amount
calculated with reference to any portion of a Tax) of any Person other than the Company or its
Subsidiaries, including under Treasury Regulations Section&nbsp;1.1502-6 (or any similar provision of
state, local or foreign law), as transferee or successor, by contract or otherwise. To the
Company&#146;s knowledge, no written claim that remains unresolved has been made by any authority in a
jurisdiction where the Company or any of its Subsidiaries has not filed Tax returns that the
Company or such Subsidiary is or may be subject to taxation by that jurisdiction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;There are no Liens with respect to material Taxes (other than Taxes not yet due and
payable) on any of the assets or properties of the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;None of the Company, any of its Subsidiaries or any predecessors of the Company or any of
its Subsidiaries by merger or consolidation has since January&nbsp;1, 2006 been a party to a transaction
intended to qualify under Section&nbsp;355 of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;The Company and its Subsidiaries have, in all material respects, maintained the books and
records required to be maintained pursuant to Section&nbsp;6001 of the Code and the rules and
regulations thereunder, and comparable Laws of the states, counties, localities and other political
divisions wherein it is required to file material Tax returns and other reports relating to
material Taxes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Neither the Company nor any of its Subsidiaries has engaged in a transaction that is
listed within the meaning of Section&nbsp;6011 of the Code and Treasury Regulations promulgated
thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;For purposes of this Agreement, &#147;<U>Tax</U>&#148; shall mean all taxes, charges, fees, levies,
imposts, duties, and other assessments, including any income, alternative minimum or add-on tax,
estimated, gross income, gross receipts, sales, use, transfer, transactions, intangibles, ad
valorem, value-added, franchise, license, capital, paid-up capital, profits, withholding, employee
withholding, payroll, worker&#146;s compensation, unemployment insurance, social security, employment,
excise, severance, stamp, transfer occupation, premium, recording, real property, personal
property, or windfall profit tax, or other tax of any kind whatsoever, together with any interest,
penalties, related liabilities, fines or additions to tax that may become payable in respect
thereof imposed by any country, any state, county, provincial or local government or subdivision or
agency thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.15. <U>Schedule&nbsp;14D-9; Offer Documents; Information Statement</U>. (a)&nbsp;None of
the information supplied or to be supplied by or on behalf of the Company or any Affiliate of the
Company for inclusion in the Offer Documents will, at the time such documents are filed with the
SEC, at the time they are mailed to stockholders of the Company, and at the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">time any amendment or supplement thereto is filed with the SEC, contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they are made, not
misleading. The Schedule&nbsp;14D&#151;9 will not, at the time it is filed with the SEC, at the time it is
mailed to stockholders of the Company, and at the time any amendment or supplement thereto is filed
with the SEC, contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they are made, not misleading. Notwithstanding the foregoing, no
representation or warranty is made by the Company with respect to information supplied in writing
by or on behalf of Parent, Purchaser or any Affiliate of Parent or Purchaser which is included in
the Offer Documents or the Schedule&nbsp;14D-9. The Schedule&nbsp;14D&#151;9 will, at the time it is filed with
the SEC, at the time it is mailed to the stockholders of the Company, and at the time any amendment
or supplement thereto is filed with the SEC, comply as to form in all material respects with the
provisions of the Exchange Act and the rules and regulations of the SEC thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The letter to stockholders, notice of meeting and information statement or proxy statement
and form of proxy, as the case may be, that may be provided to stockholders of the Company in
connection with the Merger (including any amendments or supplements) and any schedules required to
be filed with the SEC in connection therewith (collectively, the &#147;<U>Information Statement</U>&#148;)
will not, at the time the Information Statement is first mailed to stockholders of the Company, at
the time any amendment or supplement thereto is filed with the SEC, and at the time of the Special
Meeting, contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they are made, not misleading, except that no representation or warranty
is made by the Company with respect to information supplied in writing by Parent, Purchaser or any
Affiliate of Parent or Purchaser which is included in the Information Statement. The Information
Statement will, at the time the Information Statement is first mailed to stockholders of the
Company, at the time of the Special Meeting, and at the time any amendment or supplement thereto is
filed with the SEC, comply as to form in all material respects with the provisions of the Exchange
Act and the rules and regulations of the SEC promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.16. <U>Intellectual Property</U>. (a)&nbsp;As used herein, &#147;<U>Intellectual
Property</U>&#148; means, collectively, all United States and foreign (i)&nbsp;trademarks, service marks,
Internet domain names, trade dress, all applications and registrations for the foregoing, and all
goodwill associated therewith and symbolized thereby (collectively, the &#147;<U>Trademarks</U>&#148;); (ii)
inventions and discoveries, whether or not patentable, and invention disclosures (collectively, the
&#147;<U>Inventions</U>&#148;); (iii)&nbsp;patents, registrations, and applications therefor, including
divisionals, provisionals, continuations and continuations-in-part applications, and including
extensions, reexaminations and reissues (collectively, the &#147;<U>Patents</U>&#148;); (iv)&nbsp;trade secrets,
confidential information and know-how, including processes, methods, schematics, business methods,
formulae, drawings, prototypes, models and designs (collectively, the &#147;<U>Trade Secrets</U>&#148;); and
(v)&nbsp;software, copyrighted works and registrations and applications therefor, and all renewals,
extensions, restorations and reversions thereof (collectively, the &#147;<U>Copyrights</U>&#148;).
&#147;<U>Owned Intellectual Property</U>&#148; means all Intellectual Property owned by the Company.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the knowledge of the Company, the Company or one of its Subsidiaries owns or possesses
legally enforceable rights to use, in each case free and clear of any and all Liens except for
Permitted Liens, covenants and restrictions (except, in the case of licenses, the interests of the
licensing party and the terms and conditions of such licenses), all Intellectual Property necessary
to conduct the business of the Company and its Subsidiaries as currently conducted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Section&nbsp;4.16(c) of the Company Disclosure Schedule sets forth (i)&nbsp;a list of all U.S. and
foreign Patents owned by the Company or any of its Subsidiaries; (ii)&nbsp;a list of all U.S. and
foreign registered and material unregistered Trademarks (other than Internet domain names) owned by
the Company or any of its Subsidiaries; (iii)&nbsp;a list of all Internet domain names owned by the
Company or any of its Subsidiaries; (iv)&nbsp;a list of all registered Copyrights owned (in whole or in
part) by the Company or any of its Subsidiaries; and (v)&nbsp;any other material Intellectual Property
that is the subject of an application, certificate, filing, registration or other document issued,
filed with, or recorded by any Governmental Entity that is Owned Intellectual Property
(collectively, the &#147;<U>Company Registered Intellectual Property</U>&#148;), and in each case identifies
the name of the owner of such Company Registered Intellectual Property, and as applicable, the
registration number and issue or registration date or application number and filing date and the
relevant filing jurisdiction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each item of Company Registered Intellectual Property was, to the knowledge of the
Company, validly issued, is subsisting and has not expired or been cancelled or abandoned, and all
documents, recordations, certificates and fees (including filing, examination and maintenance fees)
in connection with such Company Registered Intellectual Property required to be filed or paid on or
before the Purchase Time have been filed or paid with the relevant patent, copyright, trademark or
other authorities in the United States or other jurisdictions, as the case may be. With respect to
the Owned Intellectual Property, to the knowledge of the Company, there have been no material
misrepresentations or concealment of any material information to the United States Patent and
Trademark Office or other applicable Governmental Entity. As of the date hereof, neither the
Company nor any of its Subsidiaries has received any written notice or claim (or to the knowledge
of the Company, oral notice or claim), challenging the Company&#146;s or any of its Subsidiaries&#146;
complete and exclusive ownership of the Owned Intellectual Property, or the Company&#146;s or any of its
Subsidiaries&#146; entitlement to use the Licensed-In Intellectual Property or suggesting that any other
Person has any claim of legal or beneficial ownership with respect to the Owned Intellectual
Property or (other than the licensor&#146;s interest) with respect to the Licensed-In Intellectual
Property and, to the knowledge of the Company, there is no valid basis for any such claim. As of
the date hereof, to the knowledge of the Company, no third party is infringing, violating or
misappropriating any of the Owned Intellectual Property rights of the Company or any of its
Subsidiaries. There is no claim asserted, threatened or planned to be asserted by the Company or
any of its Subsidiaries that (i)&nbsp;any third party has infringed, misappropriated or otherwise
violated any Intellectual Property rights of the Company or any of its Subsidiaries; or (ii)&nbsp;a
third party&#146;s owned or claimed Intellectual Property interferes with, infringes, dilutes or
otherwise harms any Intellectual Property rights of the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;To the knowledge of the Company, the Company has taken reasonable measures to protect the
proprietary nature of the Owned Intellectual Property. Without limiting
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the generality of the foregoing, the Company and its Subsidiaries enforce a policy of
requiring each director, officer, employee, consultant and independent contractor to execute
proprietary information, confidentiality and assignment agreements substantially in the Company&#146;s
standard forms that assign to the Company all rights to any Intellectual Property relating to the
Company&#146;s or its Subsidiaries&#146; business that is developed by the employees, consultants or
contractors, as applicable, and, except under nondisclosure or confidentiality agreements, or in
connection with the release or distribution of products of the Company or any of its Subsidiaries,
to the knowledge of the Company there has been no disclosure by the Company or any of its
Subsidiaries of its confidential information or trade secrets. To the knowledge of the Company,
other than in the ordinary course of business, no material Trade Secret of the Company or any of
its Subsidiaries has been disclosed or authorized to be disclosed to any third party not subject to
confidentiality obligations to the Company or any of its Subsidiaries and no party to a
nondisclosure agreement with Company or any of its Subsidiaries is in material breach or default
thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;To the knowledge of the Company, neither the Company nor any of its Subsidiaries is or has
been infringing, diluting, using without authorization or misappropriating, and none of the
Company, any of its Subsidiaries, any of their respective products or the conduct of their business
is or has been infringing, diluting, using without authorization or misappropriating any
Intellectual Property of any third party. Neither the Company nor any of its Subsidiaries has
received any written claim or notice alleging any such infringement, violation, dilution, use or
misappropriation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;No Owned Intellectual Property used in the business of the Company and its Subsidiaries
was developed using any facilities or resources of institutes of higher learning or under any
Contracts with any Governmental Entity. To the knowledge of the Company, none of the activities of
the employees of the Company or any of its Subsidiaries violates any Contract, arrangement or
fiduciary duty which any such employee has with a former employer, and no such former employer has
asserted in writing to the Company or any of its Subsidiaries any such violation. Section&nbsp;4.16(g)
of the Company Disclosure Schedule sets forth an accurate and complete list of any report or other
analysis prepared by or on behalf of the Company or any of its Subsidiaries regarding any of the
matters described in the preceding sentences of this clause (g), and each such report or other
analysis has been made available to Parent prior to the date of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Neither the Company nor any of its Subsidiaries has taken any action or failed to take any
action that reasonably could be expected to result in the abandonment, cancellation, forfeiture,
relinquishment, invalidation or unenforceability of any material Owned Intellectual Property
(including failure to disclose any known material prior art in connection with the prosecution of
patent applications with respect to any such Patent) nor, to the knowledge of the Company, has any
licensor (or the Company or any of its Subsidiaries, to the extent it has the right or obligation
under such license to do so) under the Licensed-In Agreements taken or failed to take any such
action in respect to the Intellectual Property licensed thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.17. <U>Environmental Matters</U>. (a)&nbsp;Except as would not have or reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;the Company and
each of its Subsidiaries comply and have complied with all applicable
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Environmental Laws (as defined below), and possess and comply with all applicable
Environmental Permits (as defined below) required under such Environmental Laws to operate as they
presently operate; (ii)&nbsp;to the knowledge of the Company, there are not Materials of Environmental
Concern (as defined below) at any property operated by the Company or its Subsidiaries, under
circumstances that are reasonably likely to result in liability of the Company nor its Subsidiaries
under any applicable Environmental Law; (iii)&nbsp;neither the Company nor its Subsidiaries has received
any written notification alleging that it is liable for, or request for information pursuant to
section 104(e) of the Comprehensive Environmental Response, Compensation and Liability Act or
similar state statute concerning, any Release or threatened Release of Materials of Environmental
Concern at any location except, with respect to any such notification or request for information
concerning any such Release or threatened Release, to the extent such matter has been resolved with
the appropriate Governmental Entity or otherwise; and (iv)&nbsp;neither the Company nor any of its
Subsidiaries has received any written claim, notice or complaint, or been subject to any
Proceeding, relating to noncompliance with Environmental Laws or any other liabilities or
obligations arising from Materials of Environmental Concern or pursuant to Environmental Laws, and
to the knowledge of the Company no such Proceeding has been threatened.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding any other representations and warranties in this Agreement, the
representations and warranties in this Section&nbsp;4.17 are the only representations and warranties in
this Agreement with respect to Environmental Laws or Materials of Environmental Concern.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For purposes of this Agreement, the following terms shall have the meanings assigned
below:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&#147;<U>Environmental Laws</U>&#148; shall mean all foreign, federal, state, or local statutes,
regulations, ordinances, codes, decrees, judgments, decisions, orders, common law, or other
requirements of Governmental Entities relating to (i)&nbsp;protection of the environment, natural
resources, or the quality of the ambient air, soil, surface water or groundwater or (ii)
Materials of Environmental Concern, in effect as of the date of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&#147;<U>Environmental Permits</U>&#148; shall mean all permits, licenses, registrations, and other
authorizations of Governmental Entities required under applicable Environmental Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&#147;<U>Materials of Environmental Concern</U>&#148; shall mean any pollutant, contaminant, waste,
or hazardous, acutely hazardous, or toxic substance defined and regulated as such or the
subject of liability under Environmental Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&#147;<U>Release</U>&#148; shall mean any release, spill, emission, leaking, pumping, injection,
deposit, disposal, discharge, dispersal, leaching or migration into the indoor or outdoor
environment, or into or out of any property, including movement through air, soil, surface
water, groundwater or property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.18. <U>Contracts</U>. (a)&nbsp;Section&nbsp;4.18 of the Company Disclosure Schedule lists,
and the Company has made available to Parent in the electronic data room true, correct and complete
copies of, each and every Contract (in each case, determined as of the date
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">hereof) to which the Company or any of its Subsidiaries is a party or by which the Company or
any of its Subsidiaries or any of their respective properties or assets is bound and which is
currently in effect or under which the Company or any of its Subsidiaries has any continuing rights
or obligations:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) that would be required to be filed by the Company as a &#147;material contract&#148; pursuant
to Item&nbsp;601(b)(10) of Regulation&nbsp;S-K under the Securities Act or disclosed by the Company on
a Current Report on Form 8-K;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) relating to the research, development, clinical trial, supply, manufacture,
marketing or co-promotion of, or collaboration with respect to, any product or product
candidate of the Company or any of its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) that is a license, sublicense or other Contract pursuant to which the Company or
any of its Subsidiaries is authorized to use any third party Intellectual Property that is
material to the business of the Company, excluding generally commercially available,
off-the-shelf software programs (the &#147;<U>Licensed-In Intellectual Property</U>&#148; and such
license, sublicense or other Contract, a &#147;<U>Licensed-In Agreement</U>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) that is a license, sublicense or other Contract pursuant to which any third party
(A)&nbsp;is authorized to use Owned Intellectual Property that is material to the business of the
Company or (B)&nbsp;has obtained and continues to have exclusive rights in Owned Intellectual
Property that is material to the business of the Company and its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) involving the payment or receipt of royalties or other amounts calculated based
upon the revenues or income of the Company or any of its Subsidiaries or income or revenues
related to any product or business activity of the Company or any of its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) that contains covenants that restrict the ability of the Company or any of its
Subsidiaries (or which, following the consummation of the Merger, could restrict the ability
of the Surviving Corporation or any of its Affiliates) to compete with any Person or in any
business, geographic area or distribution or sales channel, or to sell, supply or distribute
any service or product, except for any such Contract that may be canceled without penalty by
the Company or its Subsidiaries upon notice of sixty (60)&nbsp;days or less;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) relating to the formation, creation, operation, management or control of any
partnership or joint venture or pursuant to which the Company or any of its Subsidiaries has
an obligation (contingent or otherwise) to make an investment in or extension of credit to
any Person;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) that involves or relates to (A)&nbsp;indebtedness for borrowed money or the deferred
purchase price of goods or services and having an outstanding principal amount in excess of
$100,000 or (B)&nbsp;any exchange traded, over-the-counter or other swap, cap, floor, collar,
futures contract, forward contract, option or any other derivative financial instrument or
contract;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) under which payments are reasonably anticipated by the Company and its
Subsidiaries, as of the date hereof, to be made by or to the Company and its Subsidiaries
during the twelve (12)&nbsp;month period ending on March&nbsp;31, 2009 in excess of $100,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) with respect to any acquisition or disposition of any Person or business or
material portion thereof pursuant to which the Company or any of its Subsidiaries has
continuing indemnification, &#147;earn-out&#148; or other contingent payment obligations, in each case
that could result in payments in excess of $100,000; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) that would prevent, materially delay or materially impede the Company&#146;s ability to
consummate the Offer, the Merger or the other transactions contemplated by this Agreement.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Each such Contract described in clauses (i)&nbsp;through (xi)&nbsp;is referred to herein as a &#147;<U>Material
Contract</U>.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as would not have or reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, (i)&nbsp;each Material Contract is valid and binding on the
Company or one of its Subsidiaries and, to the knowledge of the Company, each other party thereto
and is in full force and effect, and (ii)&nbsp;the Company and its Subsidiaries have performed and
complied with all obligations required to be performed or complied with by it under each Material
Contract. Except in any case of default as would not have or reasonable be expected to have,
individually or in the aggregate, a Material Adverse Effect, (x)&nbsp;there is no default under any
Material Contract by the Company or any of its Subsidiaries or, to the knowledge of the Company, by
any other party, and (y)&nbsp;no event has occurred that with the lapse of time or the giving of notice
or both would constitute a default thereunder by the Company or any of its Subsidiaries, or to the
knowledge of the Company, by any other party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.19. <U>Affiliate Transactions</U>. No executive officer or director of the
Company or any of its Subsidiaries and, to the knowledge of the Company, no Person that currently
owns five percent (5%) or more of the Shares, is a party to any Contract with or binding upon the
Company or any of its Subsidiaries or any of their respective properties or assets or has any
interest in any property owned by the Company or has engaged in any transaction with any of the
foregoing within the last twelve (12)&nbsp;months, in each case, that is of a type that would be
required to be disclosed under Item&nbsp;404 of Regulation&nbsp;S-K under the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.20. <U>Opinion of Financial Advisor</U>. Prior to the execution of this
Agreement, J.P. Morgan Securities Inc. (the &#147;<U>Financial Advisor</U>&#148;) has delivered to the
Company Board its opinion, dated as of the date hereof, to the effect that, as of such date and
based upon and subject to the matters set forth therein, the consideration to be received by
holders of Shares in the Offer and the Merger is fair, from a financial point of view, to such
holders. Prior to the execution of this Agreement, a true, correct and complete copy of the
opinion was delivered to Parent, solely for informational purposes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.21. <U>Brokers; Certain Fees</U>. No broker, finder or investment banker is or
will be entitled to any brokerage, finder&#146;s or other fee or commission in connection with the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">transactions contemplated by this Agreement based upon arrangements made by and on behalf of
the Company or any of its Subsidiaries, except as provided in the letter agreement between the
Company and the Financial Advisor dated April&nbsp;8, 2008, a complete and correct copy of which was
delivered to Parent prior to the date of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.22. <U>Takeover Laws</U>. The Company Board has, prior to the execution of this
Agreement, (a)&nbsp;approved, for purposes of Section&nbsp;203 of the DGCL, this Agreement and the Tender
Agreements and the transactions contemplated hereby and thereby, including the Offer and the Merger
and (b)&nbsp;irrevocably resolved to elect, to the extent permitted by Law, for the Company not to be
subject to any &#147;moratorium,&#148; &#147;control share acquisition,&#148; &#147;business combination,&#148; &#147;fair price&#148; or
other form of anti-takeover Laws or regulations (collectively, &#147;<U>Takeover Laws</U>&#148;) of any
jurisdiction that may purport to be applicable to this Agreement or the transactions contemplated
hereby, which actions and resolutions have not, as of the date hereof, been subsequently rescinded,
modified or withdrawn in any way.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE V
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">REPRESENTATIONS AND WARRANTIES OF<BR>
PARENT AND PURCHASER

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in the correspondingly numbered Section of the disclosure schedule
delivered by Parent and Purchaser to the Company prior to the execution of this Agreement (the
&#147;<U>Parent Disclosure Schedule</U>&#148;) (provided, however, that a matter disclosed with respect to
one representation or warranty shall also be deemed to disclosed with respect to each other
representation or warranty to which the matter disclosed reasonably relates, but only to the extent
such relationship is reasonably apparent on the face of the disclosure contained in the Parent
Disclosure Schedule with respect to such matter), Parent and Purchaser, jointly and severally,
hereby represent and warrant to the Company as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.1. <U>Organization</U>. Each of Parent and Purchaser is a corporation or other
entity duly organized, validly existing and in good standing under the laws of the jurisdiction in
which it is incorporated or organized and has the requisite corporate or other entity power and
authority to own, operate or lease its properties and to carry on its business as it is now being
conducted, except where the failure to be so organized, existing or in good standing or to have
such power or authority would not, individually or in the aggregate, have or reasonably be expected
to have a Purchaser Material Adverse Effect. Parent owns beneficially and of record all of the
outstanding capital stock of Purchaser free and clear of all Liens. Purchaser was formed solely
for the purpose of engaging in the transactions contemplated by this Agreement and has engaged in
no business activities except as contemplated by this Agreement. &#147;<U>Purchaser Material Adverse
Effect</U>&#148; means any change, effect, event or occurrence that has a material adverse effect on the
ability of Parent or Purchaser to timely perform their respective obligations under this Agreement
or to timely consummate the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.2. <U>Authority</U>. Each of Parent and Purchaser has all necessary corporate or
other entity power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby. The execution, delivery and
performance of this Agreement by each of Parent and Purchaser and the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">consummation by each of Parent and Purchaser of the transactions contemplated hereby have been
duly and validly authorized by all necessary action of Parent and Purchaser, and no other corporate
or other entity proceedings on the part of Parent or Purchaser are necessary to authorize this
Agreement, to perform their respective obligations hereunder, or to consummate the transactions
contemplated hereby (other than the filing with the Secretary of State of the State of Delaware of
the Certificate of Merger as required by the DGCL). This Agreement has been duly and validly
executed and delivered by Parent and Purchaser and, assuming due authorization, execution and
delivery hereof by the Company, constitutes a legal, valid and binding obligation of each of Parent
and Purchaser enforceable against each of Parent and Purchaser in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
and other similar laws relating to or affecting creditors&#146; rights generally, general equitable
principles (whether considered in a proceeding in equity or at law) and any implied covenant of
good faith and fair dealing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.3. <U>No Conflict; Required Filings and Consents</U>. (a)&nbsp;The execution,
delivery and performance of this Agreement by Parent and Purchaser, do not and will not (i)
conflict with or violate the respective certificates of incorporation or bylaws (or similar
governing documents) of Parent or Purchaser, (ii)&nbsp;assuming that all consents, approvals and
authorizations contemplated by clauses (i)&nbsp;through (v)&nbsp;of subsection (b)&nbsp;below have been obtained,
and all filings described in such clauses have been made, conflict with or violate any Law or any
rule or regulation of any stock exchange applicable to Parent or Purchaser or by which either of
them or any of their respective properties are bound or (iii) (A)&nbsp;result in any breach or violation
of or constitute a default (or an event which with notice or lapse of time or both would become a
default) or (B)&nbsp;result in the loss of a benefit under, or give rise to any right of termination,
cancellation, amendment or acceleration of, or (C)&nbsp;result in the creation of any Lien on any of the
properties or assets of Parent or Purchaser under, any Contracts to which Parent, Purchaser or any
of their respective Subsidiaries is a party or by which Parent, Purchaser or any of their
respective Subsidiaries or any of their respective properties are bound, except, in the case of
clauses (ii)&nbsp;and (iii), for any such conflict, violation, breach, default, acceleration, loss,
right or other occurrence which would not have or reasonably be expected to have, individually or
in the aggregate, a Purchaser Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The execution, delivery and performance of this Agreement by each of Parent and Purchaser
and the consummation of the transactions contemplated hereby by each of Parent and Purchaser do not
and will not require any consent, approval, authorization or permit of, action by, filing with or
notification to, any Governmental Entity, except for (i)&nbsp;the applicable requirements, if any, of
the Exchange Act and the rules and regulations promulgated thereunder, and state securities,
takeover and &#147;blue sky&#148; laws, (ii)&nbsp;the applicable requirements of the HSR Act, (iii)&nbsp;the applicable
requirements of Nasdaq, (iv)&nbsp;the filing with the Secretary of State of the State of Delaware of the
Certificate of Merger as required by the DGCL, (v)&nbsp;the applicable requirements of Foreign Antitrust
Laws, and (vi)&nbsp;any such consent, approval, authorization, permit, action, filing or notification
the failure of which to make or obtain would not have or reasonably be expected to have,
individually or in the aggregate, a Purchaser Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.4. <U>Absence of Litigation</U>. There are no Proceedings pending or, to the
knowledge of Parent, threatened against Parent or any of its Subsidiaries, other than any such
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Proceedings that would not have or reasonably be expected to have, individually or in the
aggregate, a Purchaser Material Adverse Effect. As of the date hereof, neither Parent nor any of
its Subsidiaries nor any of their respective properties is or are subject to any order, writ,
judgment, injunction, decree or award, except for those that would not have or reasonably be
expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.5. <U>Offer Documents; Schedule&nbsp;14D-9; Information Statement</U>. (a)&nbsp;None of
the Offer Documents will, at the time such documents are filed with the SEC, at the time they are
mailed to the stockholders of the Company, and at the time any amendment or supplement thereto is
filed with the SEC, contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements made therein, in
light of the circumstances under which they are made, not misleading, except that no representation
is made by Parent or Purchaser with respect to information supplied in writing by or on behalf of
the Company or any Affiliate of the Company that is included therein. The Offer Documents will, at
the time the Offer Documents are filed with the SEC, at the time they are mailed to the
stockholders of the Company, and at the time any amendment or supplement thereto is filed with the
SEC, comply as to form in all material respects with the provisions of the Exchange Act and the
rules and regulations promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;None of the information supplied in writing by or on behalf of Parent, Purchaser or any
Affiliate of Parent or Purchaser that is included in the Information Statement or the Schedule
14D-9 will, at the times such documents are filed with the SEC, at the time any amendment or
supplement thereto is filed with the SEC and, in the case of the Information Statement, at the time
the Information Statement is mailed to stockholders of the Company and at the time of the Special
Meeting, contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.6. <U>Brokers</U>. No broker, finder or investment banker is or will be entitled
to any brokerage, finder&#146;s or other fee or commission from the Company in connection with the
transactions contemplated by this Agreement based upon arrangements made by and on behalf of Parent
or Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.7. <U>Financing</U>. Parent has, and as of the Closing will have, available
sufficient cash, cash equivalents and access to financing to satisfy its obligations to permit
Purchaser to purchase and pay for Shares pursuant to the Offer and to consummate the Merger and the
other transactions contemplated by this Agreement. Parent owns, directly or through one or more
wholly-owned Subsidiaries, substantially all of the assets and properties comprising the United
States geographical sector of GSK&#146;s business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.8. <U>Operations of Purchaser</U>. Purchaser has been formed solely for the
purpose of engaging in the transactions contemplated hereby and prior to the Effective Time will
have engaged in no other business activities and will have incurred no liabilities or obligations
other than as contemplated herein, except as would not have or reasonably be expected to have,
individually or in the aggregate, a Purchaser Material Adverse Effect.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VI
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">COVENANTS

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.1. <U>Conduct of Business of the Company Pending the Merger</U>. Except as
provided in or required by this Agreement, as set forth in Section&nbsp;6.1 of the Company Disclosure
Schedule or as required by applicable Law, during the period from the date of this Agreement to the
earlier of (i)&nbsp;such time as designees of Parent first constitute at least a majority of the Company
Board pursuant to Section&nbsp;1.4(a) and (ii)&nbsp;the Effective Time (such earlier time, the &#147;<U>Control
Time</U>&#148;), the Company will conduct its operations according to its ordinary and usual course of
business consistent with past practice, and the Company will, and will cause its Subsidiaries to,
use their reasonable best efforts to preserve intact their business organization, to keep available
the services of their current officers, employees and consultants and to preserve the goodwill of
and maintain satisfactory relationships with those Persons having business relationships with the
Company and its Subsidiaries. Without limiting the generality of the foregoing and except as
provided in or contemplated by this Agreement, as set forth in Section&nbsp;6.1 of the Company
Disclosure Schedule or as required by applicable Law, during the period from the date of this
Agreement to the Control Time, without the prior written consent of Parent, the Company will not,
and will cause its Subsidiaries not to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;amend or otherwise change its certificate of incorporation or bylaws or any similar
governing instruments;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;issue, deliver, sell, pledge, dispose of or encumber any Company Securities or Subsidiary
Securities or other rights of any kind to acquire or receive any Company Securities or Subsidiary
Securities, including stock appreciation rights, phantom stock or similar instruments (except for
the issuance of Shares upon the exercise of Options or the Warrants);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;declare, set aside, make or pay any dividend or other distribution, payable in cash,
stock, property or otherwise, with respect to any of its capital stock (except for any dividend or
distribution by a wholly-owned Subsidiary of the Company);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;adjust, recapitalize, reclassify, combine, split, subdivide, redeem, purchase or otherwise
acquire any shares of capital stock or other equity interests of the Company or any of its
Subsidiaries (other than the acquisition of Shares tendered by directors, officers, employees or
former employees in connection with a cashless exercise of Options or in order to pay Taxes in
connection with the exercise of Options, in each case pursuant to the terms of a Company Plan);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;make or offer to make any acquisition, by means of a merger or otherwise, of any business,
assets or securities, or any sale, lease, encumbrance or other disposition of any business, assets
or securities, in each case other than the acquisition or disposition of inventory, raw materials,
equipment and other supplies in the ordinary course of business consistent with past practice;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;enter into, amend in any material respect, renew, terminate, or grant any release or
relinquishment of any material rights under, any Material Contract (or Contract that would be a
Material Contract if entered into prior to the date hereof), including the Warrants;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;authorize or make any capital expenditures except in accordance with the Company&#146;s capital
expenditure budget set forth in Section&nbsp;6.1 of the Company Disclosure Schedule;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;incur or modify in any material respect the terms of any indebtedness for borrowed money,
or assume, guarantee or endorse, or otherwise as an accommodation become responsible for, the
obligations of any Person, or make any loans, advances or capital contributions to, or investments
in, any other Person (other than any wholly-owned Subsidiary of the Company);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) (i)&nbsp;enter into any new, or amend, or terminate any existing, employment, severance, change
of control, indemnification, termination, severance, consulting, incentive award or salary
continuation agreements or arrangements with or for the benefit of any present or former officers,
directors or employees, or grant any increases in the compensation, perquisites or benefits to
officers, directors, employees and consultants; (ii)&nbsp;except as provided in Section&nbsp;3.2, accelerate
the vesting or payment of the compensation payable or the benefits provided to any of its current
or former directors, officers, employees, consultants or service providers, or otherwise pay any
amounts not due to any such individual under applicable Law or the terms of any Company Plan,
including with respect to severance; or (iii)&nbsp;fund or make any contribution to any Company Plan or
trust not required to be funded or contributed to;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;except as permitted by the preceding clause (i), establish, adopt, enter into, amend in
any material respect (other than as required by applicable Law) or terminate any Company Plan
(including any employment, severance, consulting or other individual agreement) except as provided
in Section&nbsp;3.2, or adopt or enter into any other employee benefit plan or arrangement that would be
considered a Company Plan if it were in existence on the date of this Agreement, provided that
nothing in this Section&nbsp;6.1 shall be deemed to preclude (i)&nbsp;the termination of employment of an
employee other than an officer in the ordinary course of business consistent with past practice, or
(ii)&nbsp;the payment of severance to any such terminated employee in amounts that are consistent with
past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;make any material change in any accounting principles, except as may be appropriate to
conform to changes in statutory or regulatory accounting rules or GAAP or regulatory requirements
with respect thereto;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) (i)&nbsp;make any material Tax election or take any material position on any Tax return filed
on or after the date of this Agreement or adopt any method therein that is materially inconsistent
with elections made, positions taken or methods used in preparing or filing similar returns in
prior periods unless such position or election is required pursuant to a change in applicable Law
or the Code; (ii)&nbsp;enter into any settlement or compromise of any material Tax liability; (iii)&nbsp;file
any amended Tax returns that would result in a material change in Tax liability, taxable income or
loss; or (iv)&nbsp;enter into any closing agreement relating to any material Tax liability;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;compromise, settle or agree to settle any Proceeding (including any Proceeding relating to
this Agreement or the transactions contemplated hereby) other than compromises, settlements or
agreements in the ordinary course of business consistent with past practice that involve only the
payment of monetary damages not in excess of $100,000 individually or $300,000 in the aggregate, in
any case without the imposition of equitable relief on, or the admission of wrongdoing by, the
Company or any of its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;fail to keep in force insurance policies or replacement or revised provisions providing
insurance coverage with respect to the assets, operations and activities of the Company as are
currently in effect; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)&nbsp;agree to take any of the actions described in Sections&nbsp;6.1(a) through 6.1(n).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.2. <U>Access to Information; Confidentiality</U>. (a)&nbsp;Subject to the
restrictions imposed by the HSR Act and Foreign Antitrust Laws, from and after the date of this
Agreement until the Control Time, the Company will use best efforts to (i)&nbsp;give Parent and
Purchaser and their respective Representatives reasonable access during normal business hours to
all employees, plants, offices and other facilities and to all books, contracts, commitments and
records (including Tax returns) of the Company and its Subsidiaries and cause the Company&#146;s
Representatives to provide access to their work papers and such other information as Parent or
Purchaser may reasonably request, (ii)&nbsp;permit Parent and Purchaser to make such non-invasive
inspections as they may reasonably request, (iii)&nbsp;cause its and its Subsidiaries&#146; officers to
furnish Parent and Purchaser with such financial and operating data and other information with
respect to the business, properties and personnel of the Company as Parent or Purchaser may from
time to time reasonably request, and (iv)&nbsp;furnish promptly to Parent and Purchaser a copy of each
report, schedule and other document filed or received by the Company or any of its Subsidiaries
during such period pursuant to the requirements of the federal or state securities Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Information obtained by Parent or Purchaser pursuant to Section&nbsp;6.2(a) shall be subject to
the provisions of the Confidentiality Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Nothing in this Section&nbsp;6.2 shall require the Company to permit any inspection, or to
disclose any information, that in the reasonable judgment of the Company would (i)&nbsp;violate any of
its respective obligations with respect to confidentiality, <U>provided</U> that the Company shall
use its commercially reasonable efforts to obtain the consent of such third party to such
inspection or disclosure and shall disclose or describe such information to the fullest extent
possible consistent with such obligations, or (ii)&nbsp;result in a violation of applicable law,
including the HSR Act or Foreign Antitrust Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;No investigation by and of any party or its Representatives shall affect the
representations, warranties, covenants, agreements, rights or remedies of the parties set forth
herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.3. <U>Acquisition Proposals</U>. (a)&nbsp;Subject to Section&nbsp;6.3(b), the Company
shall not, and shall cause its Subsidiaries and Representatives not to, directly or indirectly,
from the date hereof until the Purchase Time: (i)&nbsp;initiate, solicit or knowingly
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">encourage (including by way of providing non-public information) the submission of any
Acquisition Proposal or engage in any discussions or negotiations with respect thereto or otherwise
cooperate with or assist or participate in, or knowingly facilitate any such Acquisition Proposal,
(ii)&nbsp;approve or recommend, or publicly propose to approve or recommend, an Acquisition Proposal or,
except for a confidentiality agreement contemplated pursuant to Section&nbsp;6.3(b), enter into any
merger agreement, letter of intent, agreement in principle, share purchase agreement, asset
purchase agreement or share exchange agreement, option agreement or other similar agreement
relating to an Acquisition Proposal or enter into any letter of intent, agreement or agreement in
principle requiring the Company (whether or not subject to conditions) to abandon, terminate or
fail to consummate the transactions contemplated hereby or breach its obligations hereunder, (iii)
withdraw, modify or qualify, or propose publicly to withdraw, modify or qualify, in a manner
adverse to Parent or Purchaser, the Company Board Recommendation (a &#147;<U>Change of Board
Recommendation</U>&#148;), or (iv)&nbsp;resolve, publicly propose or agree to do any of the actions described
in clause (i), (ii)&nbsp;or (iii)&nbsp;of this sentence. The Company shall immediately cease and cause to be
terminated any solicitation, encouragement, discussion or negotiation with any Persons conducted
heretofore by the Company, its Subsidiaries or any of its Representatives with respect to any
Acquisition Proposal and shall reasonably promptly request (or, to the extent the Company is
contractually permitted to do so, require) the return or destruction of all confidential
information provided by or on behalf of the Company or any of its Subsidiaries to any such Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding anything to the contrary contained in Section&nbsp;6.3(a), if at any time
following the date of this Agreement and prior to the Purchase Time, (i)&nbsp;the Company has received a
written Acquisition Proposal from a third party that is not in violation of such third party&#146;s
contractual obligations to the Company and that the Company Board believes in good faith is bona
fide, (ii)&nbsp;an intentional breach by the Company of this Section&nbsp;6.3 has not contributed to the
making of such Acquisition Proposal, and (iii)&nbsp;the Company Board determines in good faith that such
Acquisition Proposal constitutes or is reasonably likely to result in a Superior Proposal, then the
Company may, subject to clauses (x)&nbsp;and (y)&nbsp;below, (A)&nbsp;furnish information with respect to the
Company and its Subsidiaries to the Person making such Acquisition Proposal, and (B)&nbsp;participate in
discussions or negotiations with the Person making such Acquisition Proposal regarding such
Acquisition Proposal; <U>provided</U>, that (x)&nbsp;the Company will not, and will not allow its
Representatives to, disclose any non-public information to such Person unless the Company has, or
first enters into, a confidentiality agreement with such Person no less favorable to the Company
than the confidentiality agreement, dated as of February&nbsp;6, 2006, as amended, by and between the
Company and Parent, and (y)&nbsp;the Company will, as promptly as reasonably practicable, provide to
Parent any non-public information concerning the Company or its Subsidiaries provided or made
available to such other Person which was not previously provided or made available to Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;From and after the date hereof and prior to the Purchase Time, the Company shall promptly
(and in any event within twenty-four (24)&nbsp;hours) notify Parent in the event that the Company or any
of its Subsidiaries or Representatives receives (i)&nbsp;any Acquisition Proposal or indication by any
Person that it is considering making an Acquisition Proposal, (ii)&nbsp;any request for non-public
information relating to the Company or any of its Subsidiaries that, to the knowledge of the
Company, are related to any actual or potential Acquisition Proposal or (iii)&nbsp;any inquiry or
request for discussions or negotiations regarding any Acquisition
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Proposal. The Company shall provide Parent promptly (and in any event within such twenty-four (24)-hour
period) with the identity of such Person and a copy of such Acquisition Proposal, indication,
inquiry or request (or, where such Acquisition Proposal is not in writing, a description of the
material terms and conditions of such Acquisition Proposal, indication, inquiry or request),
including any modifications thereto. The Company shall keep Parent reasonably informed (orally or,
at Parent&#146;s request, in writing) on a current basis (and in any event no later than twenty-four
(24)&nbsp;hours after the occurrence of any changes, developments, discussions or negotiations) of the
status of any Acquisition Proposal, indication, inquiry or request (including the material terms
and conditions thereof and of any modification thereto), and any material developments, discussions
and negotiations, including furnishing copies of any written inquiries, correspondence and draft
documentation, and written summaries of any material oral inquiries or discussions. Without
limiting the foregoing, the Company shall promptly (and in any event within twenty-four (24)&nbsp;hours)
notify Parent orally and in writing if it determines to begin providing information or to engage in
discussions or negotiations concerning an Acquisition Proposal pursuant to Section&nbsp;6.3(b) and shall
in no event begin providing such information or engaging in such discussions or negotiations prior
to providing such notice. The Company shall not, and shall cause its Subsidiaries not to, enter
into any Contract with any Person subsequent to the date of this Agreement that would restrict the
Company&#146;s ability to provide such information to Parent, and neither the Company nor any of its
Subsidiaries is currently party to any agreement that prohibits the Company from providing the
information described in this Section&nbsp;6.3(c) to Parent. The Company (i)&nbsp;shall not, and shall cause
its Subsidiaries not to, terminate, waive, amend or modify any provision of, or grant permission or
request under, any standstill or confidentiality agreement to which it or any of its Subsidiaries
is or becomes a party, and (ii)&nbsp;shall, and shall cause its Subsidiaries to, use reasonable best
efforts to enforce the provisions of any such agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Notwithstanding anything in Section&nbsp;6.3(a) to the contrary, if (i)&nbsp;the Company receives a
written Acquisition Proposal from a third party that is not breach of such third party&#146;s
contractual obligations to the Company and that the Company Board believes in good faith is bona
fide, (ii)&nbsp;an intentional breach by the Company of this Section&nbsp;6.3 has not contributed to the
making of such Acquisition Proposal, and (iii)&nbsp;the Company Board concludes in good faith, after
consultation with outside counsel and its financial advisors, such Acquisition Proposal constitutes
a Superior Proposal after giving effect to all of the adjustments to the terms of this Agreement
which may be offered by Parent including pursuant to clause (C)&nbsp;below (an Acquisition Proposal
meeting the requirements of the foregoing clauses (i), (ii)&nbsp;and (iii), a &#147;<U>Qualifying
Proposal</U>&#148;), the Company Board may at any time prior to the Purchase Time, if it determines in
good faith, after consultation with outside counsel, that the failure to take such action is
reasonably likely to be inconsistent with its fiduciary duties to the Company&#146;s stockholders under
applicable Law, (x)&nbsp;effect a Change of Board Recommendation and/or (y)&nbsp;terminate this Agreement to
enter into a definitive agreement with respect to such Superior Proposal; <U>provided</U>,
<U>however</U>, that the Company shall not terminate this Agreement pursuant to the foregoing
clause (y), and any purported termination pursuant to the foregoing clause (y)&nbsp;shall be void and of
no force or effect, unless in advance of or substantially concurrently with such termination the
Company (1)&nbsp;pays the fee required by Section&nbsp;8.5 and (2)&nbsp;substantially concurrently with such
termination enters into the Alternative Acquisition Agreement; and <U>provided</U>,
<U>further</U>, that the Company Board may not effect a Change of Board Recommendation
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">pursuant to the foregoing clause (x)&nbsp;or terminate this Agreement pursuant to the foregoing
clause (y)&nbsp;unless (A)&nbsp;the Company shall not have materially breached this Section&nbsp;6.3, (B)&nbsp;the
Company shall have provided prior written notice to Parent, at least five (5)&nbsp;Business Days in
advance (the &#147;<U>Notice Period</U>&#148; and such notice, a &#147;<U>Qualifying Proposal Notice</U>&#148;)), of
its intention to take such action with respect to such Superior Proposal, which notice shall
specify the material terms and conditions of any such Superior Proposal (including the identity of
the party making such Superior Proposal), and shall have contemporaneously provided a copy of any
proposed definitive agreement(s) with respect to such Superior Proposal (the &#147;<U>Alternative
Acquisition Agreement</U>&#148;), (C)&nbsp;prior to effecting such Change of Board Recommendation or
terminating this Agreement to enter into a definitive agreement with respect to such Superior
Proposal, the Company shall, and shall cause its financial and legal advisors to, during the Notice
Period, negotiate with Parent in good faith (to the extent Parent desires to negotiate) to make
such adjustments in the terms and conditions of this Agreement so that such Acquisition Proposal
ceases to constitute a Superior Proposal, and (D)&nbsp;following any negotiation described in the
immediately preceding clause (C), such Acquisition Proposal continues to constitute a Superior
Proposal. In the event of any material revisions to the terms of the Superior Proposal after the
start of the Notice Period, the Company shall be required to deliver a new written notice to Parent
and to comply with the requirements of this Section&nbsp;6.3(d) with respect to such new written notice,
and the Notice Period shall be deemed to have re-commenced on the date of such new notice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company agrees that any intentional violations of the restrictions set forth in this
Section&nbsp;6.3 by any of its Representatives set forth in Section&nbsp;6.3(e) of the Company Disclosure
Schedule shall be deemed to be an intentional breach of this Agreement (including this Section&nbsp;6.3)
by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Notwithstanding anything in Section&nbsp;6.3(a) to the contrary, the Company Board may effect a
Change of Board Recommendation at any time prior to the Purchase Time, if it determines in good
faith, after consultation with outside counsel, that the failure to take such action is reasonably
likely to be inconsistent with its fiduciary duties to the Company&#146;s stockholders under applicable
Law; <U>provided</U>, <U>however</U>, that (i)&nbsp;this Section&nbsp;6.3(f) shall not apply to any Change
of Board Recommendation in connection with any Acquisition Proposal, and (ii)&nbsp;the Company shall
have provided prior written notice to Parent, at least five (5)&nbsp;Business Days in advance of its
intention to make such a Change of Board Recommendation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Nothing contained in this Section&nbsp;6.3 shall prohibit the Company Board from taking and
disclosing to the stockholders of the Company a position contemplated by Rule&nbsp;14e-2(a) and Rule
14d-9 promulgated under the Exchange Act; <U>provided</U>, that any disclosure other than (i)&nbsp;a
&#147;stop, look and listen&#148; or similar communication of the type contemplated by Rule&nbsp;14d-9(f) under
the Exchange Act, (ii)&nbsp;an express rejection of any applicable Acquisition Proposal, or (iii)&nbsp;an
express reaffirmation of its recommendation to its stockholders in favor of the Offer and the
Merger, shall be deemed to be a Change in Board Recommendation (including for purposes of Section
8.4(b)).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;The Company shall not take any action to (i)&nbsp;exempt any Person (other than Parent,
Purchaser and their respective Affiliates) from the restrictions on &#147;business combinations&#148;
contained in Section&nbsp;203 of the DGCL (or any similar provision of any other
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Law) or otherwise cause such restrictions not to apply, or (ii)&nbsp;exempt any Person (other than
Parent, Purchaser and their respective Affiliates) from the provisions on &#147;control share
acquisitions&#148; contained in any Takeover Law or otherwise cause such restrictions not to apply, in
each case unless such actions are taken simultaneously with a termination of this Agreement
pursuant to Section&nbsp;8.3(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;For purposes of this Agreement, (i) &#147;<U>Acquisition Proposal</U>&#148; means any offer or
proposal, or any indication of interest in making an offer or proposal, made or renewed by a Person
or group at any time after the date hereof which is structured to permit such Person or group to
acquire beneficial ownership of at least ten percent (10%) of the assets of, equity interest in, or
businesses of, the Company and its Subsidiaries, taken as a whole, pursuant to a merger,
consolidation or other business combination, sale of shares of capital stock, sale of assets,
tender offer or exchange offer or similar transaction, including any single or multi-step
transaction or series of related transactions, in each case other than the Merger, and (ii)
&#147;<U>Superior Proposal</U>&#148; means any bona fide Acquisition Proposal (except the references in the
definition thereof to &#147;ten percent (10%)&#148; shall be replaced by fifty percent (&#147;50%&#148;)) made in
writing after the date hereof that (x)&nbsp;includes per-Share consideration that is greater than the
Offer Price (including, only if the per-Share consideration is not all cash, a determination by the
Board of Directors in good faith, on the advice of the Financial Advisor, to such effect) and is
otherwise on terms that the Company Board has determined in its good faith judgment (after
consultation with its financial advisor and outside counsel and after taking into account all
legal, financial, regulatory and other aspects of the proposal, including the financing terms
thereof) is superior from a financial point of view to this Agreement, and (y)&nbsp;which the Company
Board has determined in good faith (after consultation with its financial advisor and outside
counsel and after taking into account all legal, financial, regulatory and other aspects of the
proposal) is reasonably capable of being consummated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.4. <U>Employment and Employee Benefits Matters</U>. (a)&nbsp;Parent shall cause the
Surviving Corporation and each of its Subsidiaries, for the period commencing at the Effective Time
and ending on December&nbsp;31, 2008, to continue to maintain for the individuals employed by the
Company at the Effective Time (the &#147;<U>Current Employees</U>&#148;) (i)&nbsp;base compensation at the levels
in effect at the Effective Time, (ii)&nbsp;the Company&#146;s 2008 annual cash bonus program as in effect at
the Effective Time and (iii)&nbsp;benefits under the employee benefit plans in effect at the Effective
Time (excluding, for this purpose, equity-based compensation); <U>provided</U>, <U>however</U>,
that nothing in this Section&nbsp;6.4 shall interfere with the Surviving Corporation&#146;s right or
obligation to make such changes as are necessary or appropriate to conform with applicable Law.
Nothing in this Section&nbsp;6.4 shall limit the right of Parent, the Surviving Corporation or any of
their Subsidiaries to terminate the employment of any Current Employee at any time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Parent will, and will cause the Surviving Corporation to, cause service rendered by
Current Employees of the Company prior to the Effective Time to be taken into account for vesting
and eligibility purposes (but not for accrual purposes, except for vacation and severance, if
applicable) under employee benefit plans of Parent, the Surviving Corporation and its Subsidiaries,
to the same extent as such service was taken into account under the corresponding Company Plans of
the Company for those purposes. Current Employees will not be subject to any eligibility
requirements or pre-existing condition limitation under any health
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">employee benefit plan of Parent, the Surviving Corporation or its Subsidiaries for any
condition for which they would have been entitled to coverage under the corresponding Company Plan
in which they participated prior to the Effective Time. Parent will, and will cause the Surviving
Corporation and its Subsidiaries, to give such Current Employees credit under such employee benefit
plans for co-payments made and deductibles and maximum out-of-pocket limitations in respect of the
year in which the Effective Time occurs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;No later than two (2)&nbsp;Business Days prior to its distribution, the Company shall provide
Parent and Purchaser with a copy of any communication intended to be made to any of its or its
Subsidiaries&#146; employees relating to the transactions contemplated hereby, and will provide an
opportunity for Parent and Purchaser to make reasonable revisions thereto that are not inconsistent
with any fiduciary obligations under ERISA.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;This Section&nbsp;6.4 shall be binding upon and inure solely to the benefit of each of the
parties to this Agreement, and nothing in this Section&nbsp;6.4, express or implied, is intended to
confer upon any other Person any rights or remedies of any nature whatsoever under or by reason of
this Section&nbsp;6.4 or is intended to be, shall constitute or be construed as an amendment to or
modification of any employee benefit plan or arrangement of Parent, the Surviving Corporation or
any of their Affiliates or limit in any way the right of Company, Parent, the Surviving Corporation
or any of their Affiliates to amend, modify or terminate any of its respective employee benefit
plans or arrangements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.5. <U>Directors&#146; and Officers&#146; Indemnification and Insurance</U>. (a)&nbsp;Parent and
Purchaser agree that, and shall cause that, the Surviving Corporation&#146;s certificate of
incorporation and bylaws shall contain provisions no less favorable with respect to indemnification
and exculpation from liabilities of the present and former directors, officers and employees of the
Company than are currently provided in the Company&#146;s Certificate of Incorporation and Bylaws, which
provisions shall not be amended, repealed or otherwise modified in any manner that would adversely
affect the rights thereunder of any such individuals until the later of (i)&nbsp;the expiration of the
statutes of limitations applicable to such matters and (ii)&nbsp;six (6)&nbsp;years from the Effective Time,
and, in the event that any Proceeding is pending or asserted or any clam made during such period,
until the disposition of any such Proceeding or claim,unless such amendment, modification or repeal
is required by applicable Law in which case Parent agrees, and shall cause the Surviving
Corporation, to make such changes to the certificate of incorporation and the bylaws as to have the
least adverse affect on the rights of .the individuals referenced in this Section&nbsp;6.5.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Without limiting any additional rights that any Person may have under any agreement or
Company Plan described in Section&nbsp;4.10 of the Company Disclosure Schedule, from and after the
Effective Time, the Surviving Corporation shall indemnify and hold harmless each present (as of the
Effective Time) or former officer and director of the Company (each, together with such person&#146;s
heirs, executors or administrators, an &#147;<U>Indemnified Party</U>&#148; and collectively, the
&#147;<U>Indemnified Parties</U>&#148;), against all claims, losses, liabilities, damages, judgments,
inquiries, fines, amounts paid in settlement and fees, costs and expenses, including attorneys&#146;
fees and disbursements, incurred in connection with any proceeding, whether civil, criminal,
administrative or investigative, arising out of or pertaining to the fact that the Indemnified
Party is or was an officer, director, employee, fiduciary or agent of the Company or
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any of its Subsidiaries, or of another entity if such service was at the request of the
Company, or any action or omission by such person in any such capacity, whether asserted or claimed
prior to, at or after the Effective Time, to the fullest extent the Surviving Corporation is
permitted to do so under applicable law and the Certificate of Incorporation or Bylaws as at the
date hereof. In the event of any such proceeding, each Indemnified Party will be entitled to
advancement of expenses incurred in the defense of the proceeding from the Surviving Corporation to
the same extent such Persons have the right to advancement of expenses from the Company as of the
date of this Agreement pursuant to the Certificate of Incorporation and Bylaws (provided that any
Person to whom expenses are advanced shall have provided an undertaking, but only to the extent
required by the DGCL, to repay such advances if it is finally determined that such Person is not
entitled to indemnification).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company shall purchase by the Effective Time tail policies to the current directors&#146;
and officers&#146; liability insurance policies maintained on the date of this Agreement by the Company,
which tail policies (i)&nbsp;shall not have an aggregate premium in excess of three hundred percent
(300%) of the aggregate annual premium most recently paid by the Company prior to the date hereof
to maintain the existing policies (which amount is set forth in Section&nbsp;6.5 of the Company
Disclosure Schedule), (ii)&nbsp;shall be effective for a period from the Effective Time through and
including the date six (6)&nbsp;years after the Effective Time with respect to claims arising from facts
or events that existed or occurred prior to or at the Effective Time, and (iii)&nbsp;shall contain
coverage that is at least as protective to such directors and officers as the coverage provided by
such existing policies (complete and accurate copies of which have been made available to Parent);
<U>provided</U>, <U>however</U>, that, if equivalent coverage cannot be obtained or can be
obtained only by paying an aggregate premium in excess of three hundred percent (300%) of such
amount, the Company shall only be required to obtain (and the Surviving Corporation shall only be
required to maintain) as much tail coverage as can be obtained by paying an aggregate premium equal
to three hundred percent (300%) of such amount. Parent shall cause such policy to be maintained in
full force and effect for its full term, and cause all obligations thereunder to be honored by the
Surviving Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;This Section&nbsp;6.5 shall survive the consummation of the Merger and is intended to benefit,
and shall be enforceable by, any Person or entity referred to in clause (a)&nbsp;of this Section&nbsp;6.5
(whether or not parties to this Agreement). The indemnification provided for in this Section&nbsp;6.5
shall not be deemed exclusive of any other rights to which the Indemnified Party is entitled
pursuant to Law or any Contract set forth in Section&nbsp;6.5(d) of the Company Disclosure Schedule. If
the Surviving Corporation or any of its successors or assigns (i)&nbsp;consolidates with or merges into
any other Person and shall not be the continuing or surviving corporation or entity resulting from
such consolidation or merger or (ii)&nbsp;transfers all or majority of its properties and assets to any
Person, then, and in each such case, proper provision shall be made so that the successors and
assigns of the Surviving Corporation shall assume the applicable obligations set forth in this
Section&nbsp;6.5.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.6. <U>Further Action; Efforts</U>. (a)&nbsp;Subject to the terms and conditions of
this Agreement, prior to the Effective Time, each party will use its commercially reasonable
efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things
necessary, proper or advisable under applicable laws and regulations to consummate the Offer, the
Merger and the other transactions contemplated by this Agreement; provided, that nothing in
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">this Section&nbsp;6.6 shall require Parent or Purchaser to keep the Offer open beyond the
expiration date set forth in the Offer (as it may be extended from time to time). In furtherance
and not in limitation of the foregoing, to the extent required under the HSR Act or Foreign
Antitrust Laws, each party hereto agrees to make an appropriate filing of a Notification and Report
Form pursuant to the HSR Act or other required filing or application under Foreign Antitrust Laws,
as applicable, with respect to the transactions contemplated hereby as promptly as practicable (and
in no event later than ten (10)&nbsp;Business Days after the date hereof), to supply as promptly as
reasonably practicable any additional information and documentary material that may be requested
pursuant to the HSR Act or such Foreign Antitrust Laws, as applicable, and to use its commercially
reasonable efforts to take all other actions necessary, proper or advisable to cause the expiration
or termination of the applicable waiting periods under the HSR Act or to obtain consent, approvals
or authorizations under Foreign Antitrust Laws as soon as practicable, including by requesting
early termination of the waiting period provided for in the HSR Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of Parent and Purchaser, on the one hand, and the Company, on the other hand, shall,
in connection with the efforts referenced in Section&nbsp;6.6(a) to obtain all requisite approvals and
authorizations for the transactions contemplated by this Agreement under the HSR Act or any Foreign
Antitrust Law, use its commercially reasonable efforts to (i)&nbsp;cooperate in all respects with each
other in connection with any filing or submission and in connection with any investigation or other
inquiry, including any proceeding initiated by a private party; (ii)&nbsp;keep the other party
reasonably informed of any communication received by such party from, or given by such party to,
the Federal Trade Commission (the &#147;<U>FTC</U>&#148;), the Antitrust Division of the Department of
Justice (the &#147;<U>DOJ</U>&#148;) or any other U.S. or foreign Governmental Entity and of any
communication received or given in connection with any proceeding by a private party, in each case
regarding any of the transactions contemplated hereby; and (iii)&nbsp;permit the other party to review
any communication given by it to, and consult with each other in advance of any meeting or
conference with, the FTC, the DOJ or any other Governmental Entity or, in connection with any
proceeding by a private party, with any other Person, and to the extent permitted by the FTC, the
DOJ or such other applicable Governmental Entity or other Person, give the other party the
opportunity to attend and participate in such meetings and conferences.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In furtherance and not in limitation of the covenants of the parties contained in Sections
6.6(a) and (b), if any objections are asserted with respect to the transactions contemplated hereby
under the HSR Act or any Foreign Antitrust Law or if any suit is instituted (or threatened to be
instituted) by the FTC, the DOJ or any other applicable Governmental Entity or any private party
challenging any of the transactions contemplated hereby as violative of the HSR Act or any Foreign
Antitrust Law or which would otherwise prevent, materially impede or materially delay the
consummation of the transactions contemplated hereby, each of Parent, Purchaser and the Company
shall use its commercially reasonable efforts to resolve any such objections or suits so as to
permit consummation of the transactions contemplated by this Agreement, including in order to
resolve such objections or suits which, in any case if not resolved, could reasonably be expected
to prevent, materially impede or materially delay the consummation of the transactions contemplated
hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;In the event that any administrative or judicial action or proceeding is instituted (or
threatened to be instituted) by a Governmental Entity or private party challenging the Merger or
any other transaction contemplated by this Agreement, or any other agreement
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">contemplated hereby, each of Parent, Purchaser and the Company shall cooperate in all respects
with each other and use its respective reasonable best efforts to contest and resist any such
action or proceeding and to have vacated, lifted, reversed or overturned any decree, judgment,
injunction or other order, whether temporary, preliminary or permanent, that is in effect and that
prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Prior to the Purchase Time, the Company shall use its reasonable best efforts to obtain
any consents, approvals or waivers of third parties with respect to any Contracts to which the
Company or any of its Subsidiaries is a party as may be necessary or appropriate for the
consummation of the transactions contemplated hereby or required by the terms of any Contract as a
result of the execution, performance or consummation of the transactions contemplated hereby;
<U>provided</U>, that in no event shall the Company or any of its Subsidiaries be required to pay
prior to the Purchase Time any fee, penalty or other consideration to any third party to obtain any
consent, approval or waiver required with respect to any such Contract.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.7. <U>Takeover Laws</U>. The Company shall, upon the request of Parent or
Purchaser, (a)&nbsp;take all reasonable steps to exclude the applicability to the Merger or any other
transaction contemplated hereby of any Takeover Laws, and (b)&nbsp;assist in any challenge by Parent or
Purchaser to the validity, or the applicability to the Offer, the Merger or any other transaction
contemplated by this Agreement, of any Takeover Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.8. <U>Information Statement</U>. Unless the Merger is consummated in accordance
with Section&nbsp;253 of the DGCL as contemplated by Section&nbsp;2.7, as soon as practicable after the
consummation of the Offer (or, if requested by Parent, prior thereto), the Company shall, subject
to the prior review and approval of Parent and Purchaser (which approval shall not be unreasonably
withheld) prepare and file with the SEC the Information Statement in preliminary form as required
by the Exchange Act and the rules and regulations promulgated thereunder. The Company shall obtain
and furnish the information required to be included in the Information Statement, shall provide
Parent and Purchaser with, and consult with Parent and Purchaser regarding, any comments that may
be received from the SEC or its staff with respect thereto, shall, subject to the prior review and
approval of Parent and Purchaser (which approval shall not be unreasonably withheld), respond
promptly to any such comments made by the SEC or its staff with respect to the Information
Statement, and shall cause the Information Statement in definitive form to be mailed to the
Company&#146;s stockholders at the earliest practicable date. If at any time prior to the Closing, any
information relating to the Offer, the Merger, the Company, Parent, Purchaser or any of their
respective Affiliates, directors or officers, should be discovered by the Company or Parent which
should be set forth in an amendment or supplement to the Information Statement, so that the
Information Statement shall not contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading, the party which
discovers such information shall promptly notify the other party, and an appropriate amendment or
supplement describing such information shall be filed with the SEC and disseminated to the
stockholders of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.9. <U>Subsequent Filings; Certain Information</U>. (a)&nbsp;Until the Control Time,
the Company shall timely file or furnish with or to the SEC each form, report and other
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">document required to be filed or furnished (as applicable) by the Company under the Exchange
Act, and will promptly deliver to Parent copies of each form, report and document filed with the
SEC. As of their respective dates, no report filed by the Company with the SEC pursuant to the
requirements of the Exchange Act, shall contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading. The audited consolidated
financial statements and unaudited interim financial statements of the Company included in such
reports, shall be prepared in accordance with GAAP applied on a consistent basis (except as may be
indicated in the notes thereto) and shall fairly present, in all material respects, the financial
position of the Company and its consolidated Subsidiaries as at the dates thereof and the results
of their operations and changes in financial position for the periods then ended, in each case in
accordance with GAAP (subject, in the case of unaudited financial statements, to normal and
recurring year-end audit adjustments which are not, individually or in the aggregate, material in
amount or significance, in each case as permitted by GAAP and the applicable rules and regulations
promulgated by the SEC).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;During the period from the date hereof to the Purchase Time, the Company shall provide or
make available to Parent in the electronic data room all material documents and data relating to
the results of all assays, preclinical and clinical trials, and any other tests, experiments,
analysis or investigations conducted by or on behalf of the Company with respect to each product or
product candidate or existing compound of the Company, to the extent such documents and data exist
in tangible form and are in the possession of the Company or its Subsidiaries after the execution
of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.10. <U>Public Announcements</U>. Each of the Company, Parent and Purchaser agrees
that no public release or announcement concerning the transactions contemplated hereby shall be
issued by any party without the prior consent of the Company and Parent (which consent shall not be
unreasonably withheld or delayed), except as such release or announcement may be required by
applicable Law or any rule or regulation of Nasdaq or any other stock exchange to which the
relevant party is subject or submits, wherever situated, in which case the party required to make
the release or announcement shall use its reasonable best efforts to allow each other party
reasonable time to comment on such release or announcement in advance of such issuance, it being
understood that the final form and content of any such release or announcement, to the extent so
required, shall be at the final discretion of the disclosing party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.11. <U>Notification</U>. The Company shall give reasonably prompt notice to
Parent, and Parent shall give reasonably prompt notice to the Company, upon obtaining knowledge of
the occurrence or non-occurrence of any event, which is reasonably likely to result in the failure
of such party to comply with or satisfy any Offer Condition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.12. <U>Approval of Compensation Actions</U>. Prior to the Purchase Time, the
Compensation Committee of the Company Board shall take all such actions as may be required to
approve, as an employment compensation, severance or other employee benefit arrangement in
accordance with the requirements of Rule&nbsp;14d-10(d)(2) under the Exchange Act and the instructions
thereto, any and all Compensation Actions taken after October&nbsp;1, 2007 and prior to the Purchase
Time that have not already been so approved.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.13. <U>Dispositions</U>. Prior to the Purchase Time, Parent and the Company shall
take all such actions as may be required (if any) to cause any dispositions of Shares (including
derivative securities with respect to Shares) resulting from the transactions contemplated by this
Agreement by each individual who is subject to the reporting requirements of Section 16(a) of the
Exchange Act with respect to the Company, to be exempt under Rule&nbsp;16b-3 promulgated under the
Exchange Act, such steps to be taken in accordance with the SEC staff No-Action Letter dated
January&nbsp;12, 1999 with respect to such subject.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.14. <U>No Control of the Company&#146;s Business</U>. Nothing contained in this
Agreement shall give Parent, directly or indirectly, the right to control or direct the Company&#146;s
or its Subsidiaries&#146; operations prior to the Control Time. Prior to the Control Time, the Company
shall exercise, consistent with the terms and conditions of this Agreement, complete control and
supervision over its and its Subsidiaries&#146; respective operations.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VII
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">CONDITIONS OF MERGER

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7.1. <U>Conditions to Obligation of Each Party to Effect the Merger</U>. The
respective obligations of each party to effect the Merger shall be subject to the satisfaction (or
waiver by the party entitled to the benefit thereof) at or prior to the Effective Time of each of
the following conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Unless the Merger is consummated pursuant to Section&nbsp;253 of the DGCL as contemplated by
Section&nbsp;2.7 of this Agreement, the &#147;agreement of merger&#148; (as such term is used in Section&nbsp;251 of
the DGCL) shall have been adopted by the Company Requisite Vote.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;No order, injunction or decree issued by any Governmental Entity of competent jurisdiction
or other legal restraint or prohibition preventing the consummation of the Merger or any of the
other transactions contemplated by this Agreement shall be in effect. No statute, rule,
regulation, order, injunction or decree shall have been enacted, entered, promulgated or enforced
(and still be in effect) by any Governmental Entity that prohibits or makes illegal consummation of
the Offer, the Merger or any other transaction contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Purchaser shall have accepted for purchase and paid for the Shares validly tendered (and
not withdrawn) pursuant to the Offer.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VIII
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">TERMINATION, AMENDMENT AND WAIVER

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.1. <U>Termination by Mutual Agreement</U>. This Agreement may be terminated and
the Offer and the Merger may be abandoned at any time prior to the Effective Time, notwithstanding
adoption thereof by the stockholders of the Company, by mutual written consent of Parent and the
Company.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->48<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.2. <U>Termination by Either Parent or the Company</U>. This Agreement may be
terminated and the Offer and the Merger may be abandoned by Parent or the Company at any time prior
to the Effective Time, notwithstanding adoption of this Agreement by the stockholders of the
Company, if any court of competent jurisdiction or other Governmental Entity shall have issued a
final order, decree or ruling or taken any other final action restraining, enjoining or otherwise
prohibiting the Offer or the Merger and such order, decree, ruling or other action is or shall have
become final and nonappealable; <U>provided</U>, <U>however</U>, that the terms of this Section
8.2 shall not be available to any party unless such party shall have used its commercially
reasonable efforts to oppose any such order, decree, ruling or other action or to have the same
vacated or made inapplicable to the Offer or the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.3. <U>Termination by the Company</U>. This Agreement may be terminated and the
Merger may be abandoned by the Company at any time prior to the Purchase Time:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;if (i)&nbsp;Purchaser fails to commence the Offer in violation of Section&nbsp;1.1 hereof, (ii)&nbsp;the
close of business on the date that is one hundred and twenty (120)&nbsp;days after the date of this
Agreement (the one hundred and twentieth (120<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>) day after the date of this Agreement,
the &#147;<U>Outside Date</U>&#148;) shall have occurred and Purchaser shall not have accepted for payment
and paid for Shares pursuant to the Offer in accordance with the terms thereof on or before such
time on the Outside Date, (iii)&nbsp;the Offer shall have expired or been terminated without Purchaser
having purchased any Shares pursuant thereto, (iv)&nbsp;Purchaser, in violation of the terms of this
Agreement, fails to accept for payment and to purchase validly tendered Shares pursuant to the
Offer, or (v)&nbsp;there shall have been a breach or inaccuracy of any representation, warranty,
covenant or agreement on the part of Parent or Purchaser contained in this Agreement, which breach
or inaccuracy would have or would reasonably be expected to have a Parent Material Adverse Effect
and which breach or inaccuracy is not capable of being cured within thirty (30)&nbsp;days following
receipt by Parent or Purchaser of written notice of such breach or inaccuracy or, if such breach or
failure is capable of being cured within such period, it has not been cured within such period;
<U>provided</U>, that the Company shall not have the right to terminate this Agreement pursuant to
this Section&nbsp;8.3(a) if any of the events or circumstances referred to in clause (i), (ii), (iii)&nbsp;or
(v)&nbsp;directly or indirectly resulted from or was caused by the Company&#146;s failure to perform in all
material respects any of its obligations under this Agreement or the failure of the Offer Condition
in Paragraph 2(c) of <U>Exhibit&nbsp;A</U> to this Agreement to be satisfied; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;in accordance with, and subject to the terms and conditions of, Section&nbsp;6.3(d)(y).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.4. <U>Termination by Parent</U>. This Agreement may be terminated and the Merger
may be abandoned by Parent at any time prior to the Purchase Time, if:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;due to an occurrence or circumstance which would result in a failure of any of the Offer
Conditions to be satisfied at any scheduled expiration of the Offer, (i)&nbsp;Purchaser shall not have
commenced the Offer within the time required by Section&nbsp;1.1, (ii)&nbsp;subject to Section&nbsp;1.1 hereof,
the Offer shall have expired or been terminated without Purchaser having purchased any Shares
pursuant thereto, or (iii)&nbsp;the Outside Date shall have occurred and Purchaser shall not have
accepted for payment Shares pursuant to the Offer on or before the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->49<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">close of business on the Outside Date; <U>provided</U>, that Parent shall not have the right
to terminate this Agreement pursuant to this Section&nbsp;8.4(a) if the failure of any of the Offer
Conditions to be satisfied or the failure of Parent to have accepted for payment Shares pursuant to
the Offer directly or indirectly resulted from or was caused by Parent&#146;s or Purchaser&#146;s failure to
perform in all material respects any of its obligations under this Agreement; <U>provided</U>,
<U>further</U>, that, if the sole unsatisfied Offer Condition is Paragraph 2(c) of <U>Exhibit
A</U> to this Agreement, such termination may be effected by Parent prior to the Outside Date only
if the breach or failure to perform or comply or to be true and correct is not capable of being
cured within thirty (30)&nbsp;days following receipt by the Company of written notice of such breach or
failure or, if such breach or failure is capable of being cured within such period, it has not been
cured within such period (it being understood that any intentional breach of Section&nbsp;6.3 shall be
deemed incapable of cure); or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;prior to the Purchase Time, (i)&nbsp;a Change of Board Recommendation shall have been effected,
or (ii)&nbsp;the Company shall have intentionally breached Section&nbsp;6.3.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.5. <U>Effect of Termination</U>. (a)&nbsp;Any termination of this Agreement by Parent
pursuant to this Article&nbsp;VIII shall also constitute an effective termination by Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as provided in Section&nbsp;8.5(c), in the event of termination of this Agreement and
the abandonment of the Merger pursuant to this Article&nbsp;VIII, this Agreement (other than Section
6.2(b) and Articles VIII and IX) shall become void and of no effect with no liability on the part
of any party (or of any of its directors, officers, employees, agents, legal and financial advisors
or other representatives); provided, however, that no such termination shall relieve any Person of
any liability or damages resulting from willful breach of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In the event that:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) this Agreement is terminated by the Company pursuant to Section&nbsp;8.3(b) or by Parent
pursuant to Section&nbsp;8.4(b); or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) this Agreement is terminated by the Company pursuant to Section&nbsp;8.3(a)(ii), and
(A)&nbsp;at any time on or after the date hereof and prior to such termination a third party
shall have made an Acquisition Proposal (whether or not conditional) to the Company Board or
the Company or shall have publicly announced an Acquisition Proposal and, in each case, not
irrevocably withdrawn such Acquisition Proposal or announcement, or any third party shall
have publicly announced an intention (whether or not conditional) to make an Acquisition
Proposal which intention has not been irrevocably withdrawn, and (B)&nbsp;any transaction
specified in the definition of &#147;Acquisition Proposal&#148; is consummated with such third party
or any other third party within 12&nbsp;months after the date of such termination or pursuant to
any agreement for an Acquisition Proposal entered into within 12&nbsp;months after the date of
such termination (or any amendment or substitute agreement); or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) this Agreement is terminated by Parent pursuant to Section&nbsp;8.4(a) as a result of
<I>either </I>(x)&nbsp;a failure of the Offer Condition set forth in Paragraph 2(c) of <U>Exhibit&nbsp;A</U>
to be satisfied, or (y)&nbsp;a failure of the Minimum Tender Condition to be satisfied at the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->50<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">expiration of the Offer in connection with which Parent has so terminated this
Agreement, and in the case of clause (x)&nbsp;or (y), (A)&nbsp;at any time on or after the date hereof
and prior to such termination a third party shall have made an Acquisition Proposal (whether
or not conditional) to the Company Board or the Company or shall have publicly announced an
Acquisition Proposal and, in each case, not irrevocably withdrawn such Acquisition Proposal
or such announcement, or such third party shall have publicly announced an intention
(whether or not conditional) to make an Acquisition Proposal which intention has not been
irrevocably withdrawn, and (B)&nbsp;any transaction specified in the definition of &#147;Acquisition
Proposal&#148; is consummated with such third party or any other third party within 12&nbsp;months
after the date of such termination or pursuant to any agreement for an Acquisition Proposal
entered into within 12&nbsp;months after the date of such termination (or any amendment or
substitute agreement);
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then in any such case, the Company shall pay Parent a termination fee of $22,500,000 (the
&#147;<U>Termination Fee</U>&#148;), by wire transfer of immediately available funds to the account or
accounts designated by Parent. Such payment shall be made (1)&nbsp;concurrently with such termination
in the case of a termination by the Company pursuant to Section&nbsp;8.3(b), (2)&nbsp;on the first
(1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP>) Business Day following the date of such termination in the case of a termination
by Parent pursuant to Section&nbsp;8.4(b), (3)&nbsp;on the first (1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP>) Business Day after the
consummation of the transaction referred to in clause (B)&nbsp;of Section&nbsp;8.5(c)(ii), in the case of a
termination fee payable pursuant to Section&nbsp;8.5(c)(ii), and (4)&nbsp;on the first (1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP>)
Business Day after the consummation of the transaction referred to in clause (B)&nbsp;of Section
8.5(c)(iii), in the case of a termination fee payable pursuant to Section&nbsp;8.5(c)(iii). For the
avoidance of doubt, the Company shall not be required to pay a termination fee pursuant to more
than one clause of this Section&nbsp;8.5(c). For purposes of this Section&nbsp;8.5(c), &#147;Acquisition
Proposal&#148; shall have the meaning ascribed thereto in Section&nbsp;6.3(h) except that references in the
definition to &#147;ten percent (10%)&#148; shall be replaced by &#147;fifty percent (50%)&#148;.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If Parent timely receives the Termination Fee pursuant to Section&nbsp;8.5(b), termination of
this Agreement and the collection of such fee shall be the sole and exclusive remedy of Parent and
Purchaser in respect of any breach of, or inaccuracy contained in, the Company&#146;s covenants,
agreements, representations or warranties contained herein, other than a willful breach of the
Company&#146;s covenants or agreements contained herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company acknowledges that the agreements contained in Section&nbsp;8.5(c) are an integral
part of the transactions contemplated by this Agreement, and that, without these agreements, Parent
or Purchaser would not have entered into this Agreement; accordingly, if the Company fails to
promptly pay any amount due pursuant to Section&nbsp;8.5(c), as applicable, and, in order to obtain such
payment, Parent commences a suit which results in a judgment in favor of Parent for the fee set
forth in this Section&nbsp;8.5, the Company shall pay any costs and expenses (including attorneys&#146; fees)
in connection with such suit, together with interest from the date of termination of this Agreement
on the amounts owed at the prime rate of Citibank N.A. in effect from time to time during such
period plus two percent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.6. <U>Expenses</U>. Except as otherwise specifically provided herein, each party
shall bear its own expenses in connection with this Agreement and the transactions contemplated
hereby. Expenses incurred in connection with the printing and mailing of the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->51<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Information Statement, the Offer Documents and the Schedule&nbsp;14D-9 shall be shared equally by
Parent and the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.7. <U>Amendment</U>. This Agreement may be amended by the parties hereto by
action taken by or on behalf of their respective Boards of Directors at any time prior to the
Effective Time, whether before or after adoption of this Agreement by the stockholders of the
Company; provided, however, that, (i)&nbsp;after Purchaser purchases any Shares pursuant to the Offer,
no amendment shall be made which decreases the Merger Consideration, and (ii)&nbsp;after adoption of
this Agreement by the stockholders of the Company, no amendment may be made which by Law or any
applicable rule or regulation of any stock exchange requires the further approval of the
stockholders of the Company without such further approval. This Agreement may not be amended
except by an instrument in writing signed by the parties hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.8. <U>Waiver</U>. At any time prior to the Effective Time, any party hereto may
(i)&nbsp;extend the time for the performance of any of the obligations or other acts of the other
parties hereto, (ii)&nbsp;waive any inaccuracies in the representations and warranties contained herein
or in any document delivered pursuant hereto, and (iii)&nbsp;subject to the requirements of applicable
Law, waive compliance by the other parties with any of the agreements or conditions contained
herein, except that the Minimum Tender Condition may only be waived by Purchaser with the prior
written consent of the Company. Any such extension or waiver shall be valid if set forth in an
instrument in writing signed by the party or parties to be bound thereby. The failure of any party
to assert any rights or remedies shall not constitute a waiver of such rights or remedies.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE IX
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">GENERAL PROVISIONS

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.1. <U>Non-Survival of Representations, Warranties, Covenants and Agreements</U>.
None of the representations, warranties, covenants and agreements in this Agreement or in any
instrument delivered pursuant to this Agreement, including any rights arising out of any breach of
such representations, warranties, covenants and agreements, shall survive the Effective Time,
except for (i)&nbsp;those covenants and agreements contained herein that by their terms apply or are to
be performed in whole or in part after the Effective Time and (ii)&nbsp;this Article&nbsp;IX.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.2. <U>Notices</U>. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given (and shall be deemed to have been
duly given upon receipt) (i)&nbsp;when delivered, if delivered in Person, (ii)&nbsp;when sent, if sent by
facsimile or electronic mail, provided that any facsimile or electronic sent is promptly confirmed
by telephone, (iii)&nbsp;five (5)&nbsp;Business Days after sending, if sent by registered or certified mail
(postage prepaid, return receipt requested) and (iv)&nbsp;one (1)&nbsp;Business Day after sending, if sent by
overnight delivery, in each case to the respective parties at the following addresses (or at such
other address for a party as shall be specified by like notice):
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->52<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;if to Parent or Purchaser:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">SmithKline Beecham Corporation<BR>
200 N. 16th Street (FP2355)<BR>
Philadelphia, PA 19102<BR>
Attention: Carol G. Ashe<BR>
Facsimile: 215-751-5349<BR>
Email: carol.g.ashe@gsk.com
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 6%; margin-top: 6pt">with an additional copy (which shall not constitute notice) to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">Cleary Gottlieb Steen &#038; Hamilton LLP<BR>
One Liberty Plaza<BR>
New York, NY 10006<BR>
Attention: Victor I. Lewkow, Esq.<BR>
Facsimile: 212-225-3999<BR>
Email: vlewkow@cgsh.com
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;if to the Company:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">Sirtris Pharmaceuticals, Inc.<BR>
200 Technology Square<BR>
Cambridge, MA 02139<BR>
Attention: Garen Bohlin, Chief Operating Officer<BR>
Facsimile: 617-252-6924<BR>
Email: gbohlin@sirtrispharma.com
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 6%; margin-top: 6pt">with an additional copy (which shall not constitute notice) to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">Ropes &#038; Gray LLP<BR>
One International Place<BR>
Boston, MA 02110<BR>
Attention: Marc A. Rubenstein, Esq.<BR>
Facsimile: 617-951-7050<BR>
Email: marc.rubenstein@ropesgray.com
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.3. <U>Certain Definitions</U>. For purposes of this Agreement, the term:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &#147;<U>Affiliate</U>&#148; of a Person means a Person that directly or indirectly, through one or
more intermediaries, controls, is controlled by, or is under common control with, the first
mentioned Person;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &#147;<U>beneficial owner</U>&#148; with respect to any Shares has the meaning ascribed to such
term under Rule&nbsp;13d-3 under the Exchange Act (and the term &#147;<U>beneficially owned</U>&#148; or
&#147;<U>owns beneficially</U>&#148; shall have a corresponding meaning);
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->53<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &#147;<U>Business Day</U>&#148; means any day on which the principal offices of the SEC in
Washington, D.C. are open to accept filings or, in the case of determining a date when any payment
is due, any day on which banks are not required or authorized by law to close in New York, New
York;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) &#147;<U>control</U>&#148; (including the terms &#147;<U>controlled</U>&#148;, &#147;<U>controlled by</U>&#148; and
&#147;<U>under common control with</U>&#148;) means the possession, directly or indirectly or as trustee or
executor, of the power to direct or cause the direction of the management policies of a Person,
whether through the ownership of stock, as trustee or executor, by contract or credit arrangement
or otherwise;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) &#147;<U>GAAP</U>&#148; means United States generally accepted accounting principles;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) &#147;<U>knowledge</U>&#148; means, with respect to any Person, the actual knowledge of any senior
executive officer of such Person and the knowledge that such Person would have obtained in the
prudent discharge of his or her ordinary job responsibilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) &#147;<U>Parent Material Adverse Effect</U>&#148; means any change, effect, event or occurrence
that prevents or materially impairs the ability of Parent or Purchaser to consummate the Offer, the
Merger or any of the other transactions contemplated by this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) &#147;<U>Person</U>&#148; means an individual, corporation, partnership, limited liability company,
association, trust, unincorporated organization, other entity or group (as defined in Section
13(d)(3) of the Exchange Act);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) &#147;<U>Subsidiary</U>&#148; of the Company, the Surviving Corporation, Parent or any other Person
means any corporation, partnership, joint venture or other legal entity of which the Company, the
Surviving Corporation, Parent or such other Person, as the case may be (either alone or through or
together with any other Subsidiary), owns, directly or indirectly, voting stock or other equity
interests having ordinary voting power to elect a majority of the board of directors or other
governing body of such corporation or other legal entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.4. <U>Severability</U>. If any term or other provision of this Agreement is
invalid, illegal or incapable of being enforced by any rule of law or public policy, the remaining
provisions of this Agreement shall be enforced so as to effect the original intent of the parties
as closely as possible in an acceptable manner to the end that the transactions contemplated hereby
are fulfilled to the fullest extent possible.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.5. <U>Entire Agreement; Assignment</U>. This Agreement (including the Exhibits
hereto), the Company Disclosure Schedule, Parent Disclosure Schedule and the Confidentiality
Agreement constitute the entire agreement among the parties with respect to the subject matter
hereof and supersede all prior agreements and undertakings, both written and oral, among the
parties, or any of them, with respect to the subject matter hereof. This Agreement shall not be
assigned by operation of law or otherwise without the prior written consent of each of the other
parties, except that Parent may assign all or any of its rights and obligations hereunder to any
direct or indirect wholly-owned Subsidiary of Parent; <U>provided</U>, <U>however</U>, that no
such assignment shall relieve Parent from any of its obligations hereunder.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->54<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.6. <U>Parties in Interest</U>. This Agreement shall be binding upon and inure
solely to the benefit of each party hereto. Nothing in this Agreement, express or implied, is
intended to or shall confer upon any Person (other than the parties hereto) any right, benefit or
remedy of any nature whatsoever under or by reason of this Agreement except for the rights,
benefits and remedies granted to the Indemnified Parties under Section&nbsp;6.5. For the avoidance of
doubt, it is expressly understood and agreed that the provisions of Section&nbsp;6.4 are statements of
intent and no employees or other Person (including any party hereto) shall have any rights or
remedies, including rights of enforcement, with respect thereto and no employee or other Person is,
is intended to be or shall be deemed to be a third-party beneficiary thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.7. <U>Governing Law</U>. This Agreement shall be governed by, and construed in
accordance with, the laws of the State of Delaware, without giving effect to the choice of law
rules or principles (whether of the State of Delaware or any other jurisdiction) that would cause
the application of the laws of any other jurisdiction other than the State of Delaware.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.8. <U>Headings</U>. The descriptive headings contained in this Agreement are
included for convenience of reference only and shall not affect in any way the meaning or
interpretation of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.9. <U>Counterparts</U>. This Agreement may be executed and delivered (including
by facsimile transmission) in two or more counterparts, and by the different parties hereto in
separate counterparts, each of which when executed shall be deemed to be an original but all of
which taken together shall constitute one and the same agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.10. <U>Performance Guaranty</U>. Parent hereby guarantees the due, prompt and
faithful performance and discharge by, and compliance with, all of the obligations covenants,
terms, conditions and undertakings of Purchaser under this agreement in accordance with the terms
hereof including any such obligations, covenants, terms, conditions and undertakings that are
required to be performed discharged or complied with.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.11. <U>Specific Performance; Jurisdiction</U>. (a)&nbsp;The parties agree that
irreparable damage would occur in the event that any of the provisions of this Agreement were not
performed in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of
this Agreement and to enforce specifically the terms and provisions of this Agreement in the Court
of Chancery of the State of Delaware or, if under applicable Law exclusive jurisdiction over such
matter is vested in the federal courts, any court of the United States located in the State of
Delaware, this being in addition to any other remedy to which such party is entitled at law or in
equity. In addition, each of the parties hereto (i)&nbsp;consents to submit itself to the personal
jurisdiction of the Court of Chancery of the State of Delaware or any court of the United States
located in the State of Delaware in the event any dispute arises out of this Agreement or any of
the transactions contemplated by this Agreement, (ii)&nbsp;agrees that it will not attempt to deny or
defeat such personal jurisdiction by motion or other request for leave from any such court, and
(iii)&nbsp;agrees that it will not bring any action or proceeding relating to this Agreement or any of
the transactions contemplated by this Agreement in any court other than the Court of Chancery of
the State of Delaware or, if under applicable law exclusive jurisdiction
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->55<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">over such matter is vested in the federal courts, any court of the United States located in
the State of Delaware.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL
BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS
AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS, INCLUDING
THE OFFER AND MERGER, CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT
(A)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF
SUCH WAIVERS, (B)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C)&nbsp;IT MAKES
SUCH WAIVERS VOLUNTARILY, AND (D)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER
THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.11(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.12. <U>Interpretation</U>. When reference is made in this Agreement to a Section,
such reference shall be to a Section of this Agreement unless otherwise indicated. Whenever the
words &#147;include&#148;, &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be
followed by the words &#147;without limitation.&#148; The words &#147;hereof,&#148; &#147;herein,&#148; &#147;hereby&#148; and &#147;hereunder&#148;
and words of similar import when used in this Agreement shall refer to this Agreement as a whole
and not to any particular provision of this Agreement. The word &#147;or&#148; shall not be exclusive.
Whenever used in this Agreement, any noun or pronoun shall be deemed to include the plural as well
as the singular and to cover all genders. This Agreement shall be construed without regard to any
presumption or rule requiring construction or interpretation against the party drafting or causing
any instrument to be drafted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.13. <U>No Other Representations or Warranties</U>. (a)&nbsp;Except for the
representations and warranties contained this Agreement, neither the Company nor any other Person
on behalf of the Company or any of its Subsidiaries makes any other express or implied
representation or warranty with respect to the Company or any of its Subsidiaries or with respect
to any other information provided by the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except for the representations and warranties contained in this Agreement, none of Parent,
Purchaser or any other Person on behalf of Parent or Purchaser makes any other express or implied
representation or warranty with respect to Parent or Purchaser or with respect to any other
information provided to the Company.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;<I>Remainder of Page Left Blank Intentionally</I>&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->56<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, each of Parent, Purchaser and the Company has caused this Agreement to be
executed as of the date first written above by their respective officers thereunto duly authorized.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SMITHKLINE BEECHAM CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Carol G. Ashe
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Carol G. Ashe&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President and Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Signature Page to Agreement and Plan of Merger
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, each of Parent, Purchaser and the Company has caused this Agreement to be
executed as of the date first written above by their respective officers thereunto duly authorized.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">FOUNTAIN ACQUISITION CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Carol G. Ashe
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Carol G. Ashe&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Signature Page to Agreement and Plan of Merger
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, each of Parent, Purchaser and the Company has caused this Agreement to be
executed as of the date first written above by their respective officers thereunto duly authorized.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SIRTRIS PHARMACEUTICALS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Christoph Westphal
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Christoph Westphal&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President, Chief Executive Officer
and Vice Chairman&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">             /s/ Garen Bohlin
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Garen Bohlin&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Chief Operating Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Signature Page to Agreement and Plan of Merger
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>EXHIBIT A</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>CONDITIONS TO THE OFFER</U>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capitalized terms used in this <U>Exhibit&nbsp;A</U> and not otherwise defined herein shall have
the meanings assigned to them in the Agreement to which it is attached (the &#147;<U>Merger
Agreement</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;Notwithstanding any other provision of the Offer or the Merger Agreement, Purchaser shall
not be required to accept for payment or, subject to any applicable rules and regulations of the
SEC, including Rule&nbsp;14e-l(c) under the Exchange Act (relating to Purchaser&#146;s obligation to pay for
or return tendered Shares promptly after the termination or withdrawal of the Offer), to pay for
any Shares tendered in connection with the Offer and may terminate or, subject to the terms of the
Merger Agreement, amend the Offer, unless, immediately prior to the expiration of the offering
period for the Offer, as the same may be extended from time to time (the &#147;<U>Expiration
Date</U>&#148;):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;there shall have been validly tendered in the Offer and not properly withdrawn that number
of Shares which, together with the number of Shares, if any, then owned beneficially by GSK, Parent
and Purchaser (together with their wholly-owned Subsidiaries), constitutes at least a majority of
the total number of then-outstanding Shares on a fully diluted basis (which shall mean, as of any
time, the number of Shares outstanding, together with all Shares (if any) which the Company would
be required to issue, after giving effect to Sections&nbsp;3.2(a) and 3.2(b), pursuant to any then
outstanding warrants, options, benefit plans or obligations or securities convertible or
exchangeable into Shares or otherwise, whether or not then exercisable) (the &#147;<U>Minimum Tender
Condition</U>&#148;); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the applicable waiting period under the HSR Act in respect of the transactions
contemplated by this Agreement shall have expired or been terminated, and any required approvals or
consents in respect of the transactions contemplated by this Agreement shall have been obtained
under any applicable Foreign Antitrust Laws (and any applicable waiting periods thereunder have
expired or been terminated).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;Additionally, notwithstanding any other provision of the Offer or the Merger Agreement,
Purchaser shall not be required to accept for payment or, subject to any applicable rules and
regulations of the SEC, including Rule&nbsp;14e-l(c) under the Exchange Act (relating to Purchaser&#146;s
obligation to pay for or return tendered Shares promptly after the termination or withdrawal of the
Offer), to pay for any Shares tendered in connection with the Offer and may terminate or, subject
to the terms of the Merger Agreement, amend the Offer if any of the following conditions exist:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) there shall have been any Law, decree, judgment, order or injunction, promulgated,
enacted, entered, enforced, issued or amended by any Governmental Entity that would, or is
reasonably likely to: (i)&nbsp;restrain, enjoin or otherwise prohibit the making or consummation
of the Offer or the Merger or the other transactions contemplated by the Merger Agreement;
or (ii)&nbsp;impose material limitations on the ability of Parent, Purchaser or any of their
respective Subsidiaries or Affiliates to acquire or hold, transfer or dispose of, or
effectively to exercise all rights of ownership of, some or all of the Shares
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->A-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">including the right to vote the Shares purchased by Purchaser pursuant to the Offer on
an equal basis with all other Shares on all matters properly presented to the stockholders
of the Company;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) there shall be pending or threatened (and such threat shall not have been
withdrawn), any action, proceeding or counterclaim by any Governmental Entity challenging
any of the making or consummation of the Offer or the Merger or the other transactions
contemplated by the Merger Agreement or seeking, directly or indirectly, to result in any of
the consequences referred to in clauses (i)&nbsp;and (ii)&nbsp;of Paragraph 2(a) above (provided, that
any action, proceeding or counterclaim by a foreign or municipal Governmental Entity shall
not cause this condition to fail to be satisfied unless such action, proceeding or
counterclaim is reasonably likely to succeed);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) (i)&nbsp;the Company shall have breached or failed to comply in any material respect
with any of its obligations, covenants, or agreements under the Merger Agreement, or (ii)
any representation or warranty of the Company contained in the Merger Agreement shall not be
true and correct; <U>provided</U>, that, for purposes of this Paragraph&nbsp;2(c):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) all such representations and warranties shall be interpreted without giving
effect to the words &#147;materially&#148; or &#147;material&#148; or to any qualification based on such
terms or based on the defined term &#147;Material Adverse Effect&#148;;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) any such representation or warranty contained in Section&nbsp;4.1(b) or Section
4.3 shall be deemed untrue if it shall fail to be true and correct in all but <I>de
minimis </I>respects;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) any such representation or warranty (other than any representation or
warranty referred to in clause (B)&nbsp;above) shall be deemed untrue if such
representation or warranty shall fail to be true and correct in all respects except
where the fact, circumstance, change or event giving rise to any such failure of all
such representations and warranties to be true and correct has not had and would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">in each case at any scheduled expiration of the Offer (except for any representation or
warranty that is expressly made as of a specified date, in which case as of such specified
date); or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the Merger Agreement shall have been terminated pursuant to its terms or shall have
been amended pursuant to its terms to provide for such termination or amendment of the
Offer;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">which, in the reasonable judgment of Parent or Purchaser, in any case, makes it inadvisable to
proceed with the Offer or with acceptance for payment or payment for Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The conditions set forth in Paragraphs 1 and 2 of this <U>Exhibit&nbsp;A</U> are for the benefit
of Parent and Purchaser and, regardless of the circumstances, may be asserted by Parent or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->A-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Purchaser in whole or in part at any applicable time or from time to time prior to the
Expiration Date, except that the conditions relating to receipt of any approvals from any
Governmental Entity may be asserted at any time prior to payment of the Offer Price for Shares, and
all conditions (except for the Minimum Tender Condition) may be waived by Parent or Purchaser in
its discretion in whole or in part at any applicable time or from time to time, in each case
subject to the terms and conditions of the Merger Agreement and the applicable rules and
regulations of the SEC. The failure of Parent or Purchaser at any time to exercise any of the
foregoing rights shall not be deemed a waiver of any such right and each such right shall be deemed
an ongoing right that may be asserted at any time and from time to time.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->A-3<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
